Skip to main content
PLOS Pathogens logoLink to PLOS Pathogens
. 2020 Sep 24;16(9):e1008826. doi: 10.1371/journal.ppat.1008826

The C. elegans GATA transcription factor elt-2 mediates distinct transcriptional responses and opposite infection outcomes towards different Bacillus thuringiensis strains

Alejandra Zárate-Potes 1,¤a, Wentao Yang 1,¤b, Barbara Pees 1,¤c, Rebecca Schalkowski 1,¤d, Philipp Segler 1, Bentje Andresen 1, Daniela Haase 1, Rania Nakad 1, Philip Rosenstiel 2, Guillaume Tetreau 3, Jacques-Philippe Colletier 3, Hinrich Schulenburg 1,4,‡,*, Katja Dierking 1,‡,*
Editor: James J Collins III5
PMCID: PMC7513999  PMID: 32970778

Abstract

The nematode Caenorhabditis elegans has been extensively used as a model for the study of innate immune responses against bacterial pathogens. While it is well established that the worm mounts distinct transcriptional responses to different bacterial species, it is still unclear in how far it can fine-tune its response to different strains of a single pathogen species, especially if the strains vary in virulence and infection dynamics. To rectify this knowledge gap, we systematically analyzed the C. elegans response to two strains of Bacillus thuringiensis (Bt), MYBt18247 (Bt247) and MYBt18679 (Bt679), which produce different pore forming toxins (PFTs) and vary in infection dynamics. We combined host transcriptomics with cytopathological characterizations and identified both a common and also a differentiated response to the two strains, the latter comprising almost 10% of the infection responsive genes. Functional genetic analyses revealed that the AP-1 component gene jun-1 mediates the common response to both Bt strains. In contrast, the strain-specific response is mediated by the C. elegans GATA transcription factor ELT-2, a homolog of Drosophila SERPENT and vertebrate GATA4-6, and a known master regulator of intestinal responses in the nematode. elt-2 RNAi knockdown decreased resistance to Bt679, but remarkably, increased survival on Bt247. The elt-2 silencing-mediated increase in survival was characterized by reduced intestinal tissue damage despite a high pathogen burden and might thus involve increased tolerance. Additional functional genetic analyses confirmed the involvement of distinct signaling pathways in the C. elegans defense response: the p38-MAPK pathway acts either directly with or in parallel to elt-2 in mediating resistance to Bt679 infection but is not required for protection against Bt247. Our results further suggest that the elt-2 silencing-mediated increase in survival on Bt247 is multifactorial, influenced by the nuclear hormone receptors NHR-99 and NHR-193, and may further involve lipid metabolism and detoxification. Our study highlights that the nematode C. elegans with its comparatively simple immune defense system is capable of generating a differentiated response to distinct strains of the same pathogen species. Importantly, our study provides a molecular insight into the diversity of biological processes that are influenced by a single master regulator and jointly determine host survival after pathogen infection.

Author summary

Although invertebrates possess a comparatively simple immune system, research over the past decades revealed that a complexity of different signaling processes interact to produce fine-tuned defense responses to various pathogenic challenges. To date, however, it is still largely unexplored to what extent invertebrates generate a differentiated response against different strains of a given pathogen species. Here, we used the nematode C. elegans as a model to elucidate the common and, importantly, distinct defense responses directed at different strains of the same pathogen taxon, Bacillus thuringiensis (Bt), which vary in infection characteristics. We found that silencing of a single GATA transcriptional regulator causes protection against one Bt strain but sensitization against another. The protection is multifactorial and most likely mediated via tolerance (i.e., ability to limit cellular damage despite high pathogen burden), while sensitization results from decreased resistance (i.e., ability to limit pathogen burden through induction of antimicrobial effectors). Our work demonstrates that invertebrate defense responses against two different strains of the same pathogen species can be distinct, that they likely involve tolerance against one of the strains and are mediated by a single transcription factor as a central master switch.

Introduction

In nature animal hosts are commonly exposed to different strains of a given pathogen species, which may vary in virulence factor expression and infection dynamics. It is however largely unknown how such variation between multiple pathogen strains of a given species affect the host’s first line of defense: the innate immune response. Invertebrates are excellent models to address this question because they rely exclusively on innate immunity to fight pathogen threats. While it is established that distinct signaling pathways regulate invertebrate defense responses to broadly different groups of pathogens [13], phenotypic evidence suggests that invertebrate defense responses can even be distinct between different strains of the same pathogen species [411]. However, only few studies directly tested how different strains of a pathogen affect the host immune response. In bumblebees, transcriptome analyses revealed striking differences in the host gene expression response to different genotypes of the trypanosome gut parasite Crithidia bombi, which vary in infectivity [12]. In the fruit fly Drosophila melanogaster, different genotypes of the parasitoid wasp Leptopilina boulardi, which differ in virulence, differentially affect cellular and humoral immune responses [13]. Similarly, in the schistosomiasis vector snail Biomphalaria glabrata different strains of Schistosoma parasites induce common and distinct host expression responses and combinatorial activation of putative pathogen recognition molecules have been proposed to explain specificity of immunological memory in this system [9]. Yet, these findings only apply to eukaryotic parasites and have not been validated by functional genetic analysis. In sum, little is known about whether and how different strains of bacterial pathogen species induce differential invertebrate immune responses.

The nematode Caenorhabditis elegans is one of the main models to study the function of the innate immune system against bacterial pathogens. C. elegans is known to express common, but also specific transcriptional responses towards distantly related bacterial pathogen species with different virulence mechanisms and infection dynamics [1419]. It is proposed on the one hand, that the C. elegans general response to pathogens includes the activation of central transcriptional regulators, such as the GATA family of transcription factors and conserved innate immune and stress response pathways [14,17]. On the other hand, the distinct responses to different pathogen species are proposed to be regulated by joint action of different transcription factors and mediated by potentially specific antimicrobial effectors [14,17,20,21]. Yet, to date, it remains unknown how distinct strains within a bacterial species differentially influence the nematode’s immune response. Here we addressed this question by analyzing the C. elegans response to two closely related strains of Bacillus thuringiensis (Bt) that produce different pore forming toxins (PFTs) and vary in infection dynamics.

Bt is characterized by expression of a variety of crystal (Cry) PFTs that define to a large extent the bacterium’s host specificity, including pathogenicity towards nematodes [22]. The C. elegans defense response to Escherichia coli expressing the single three-domain (3d) Cry toxin Cry5B was studied in detail previously and several signaling pathways required for defense against Cry5B were identified [2329]. One study assessed the proteomic response of C. elegans to E. coli expressing Cry6Aa, which exhibits a distinct protein structure from Cry5B [30]. As yet, however, the molecular basis of specific interactions between C. elegans and distinct Bt strains in a natural infection setting has not been systematically analyzed. In this study we focused on two nematocidal Bt strains MYBt18247 (Bt247) and MYBt18679 (Bt679), which belong to the same bacterial species but vary in pathogenicity [3133], in the Cry PFTs produced, and most likely also in the expression of additional virulence factors [31,32,34,35]. The strain Bt407 served as a non-pathogenic, non-Cry PFT-producing control [36]. The generally more virulent Bt679 produces the nematocidal 3d-Cry PFTs Cry21Aa3 (Cry21Aa) and Cry14Aa2 (Cry14Aa) [32], while the generally less virulent Bt247 only expresses a unique, structurally distinct toxin, Cry6Ba [31]. Despite the differences in structure (and potential mechanism of action) of these Cry toxins, the form of cellular damage they cause is similar in that they all penetrate the target cell membrane and generate pores, eventually leading to cell death.

We used cytopathological analyses by transmission electron microscopy (TEM) and a transcriptomic approach to assess the infection dynamics and the response of C. elegans to these two pathogen strains. We subsequently combined functional genetic analysis, additional transcriptomic data, comprehensive phenotyping and microscopic analyses to further characterize the common and distinct responses to Bt247 and Bt679. We found that there are, indeed, distinct responses to the two Bt strains. These are mediated by the intestinal GATA transcription factor ELT-2 and further involve resistance to infection to Bt679 and shifts in lipid metabolism, detoxification, and trehalose catabolism that putatively lead to tolerance to infection with Bt247.

Results and discussion

Bt247 and Bt679 vary in cytopathology and infection dynamics

We first investigated differences in infection dynamics between Bt247 and Bt679 when we infected worms with the same concentration of Bt spores. We here define infection as the accumulation of Bt spores inside the worm’s gut and/or proliferation of Bt vegetative cells in the gut or throughout the whole worm body. Spore accumulation in the gut and proliferation of vegetative cells in dead worms haves been repeatedly shown for both Bt247 and Bt679 in the past [31,32,34,35] (see also below). In detail, transmission electron microscopy (TEM) of cross sections of the C. elegans intestine from Bt247- and Bt679-infected living worms were inspected 2 hours (h), 6 h, 12 h, and 24 h post infection (p.i.) (Fig 1A) and compared to worms exposed to non-pathogenic Bt407 or to the C. elegans laboratory food bacterium E. coli OP50 (Fig 1B–1Q). In the E. coli-fed control worms, all bacteria were broken up, and the worm displayed a thin intestinal lumen with normal, long and straight microvilli (Fig 1E, 1I, 1M and 1Q). C. elegans on the non-pathogenic Bt407 displayed slightly widened intestinal lumens and accumulation of Bt407 spores at later time points (12 h and 24 h p.i.), but also no signs of tissue damage (Fig 1D, 1H, 1L and 1P). Infection with Bt679, however, resulted in severe tissue damage as early as 6 h p.i. (Fig 1C and 1G), leading to early spore germination (12 h p.i.), accumulation of vegetative cells, and host killing (Fig 1K and 1O). In contrast, infection with Bt247 resulted in gradually increasing damage of intestinal tissue and accumulation of spores in the intestinal lumen over time, but apparently no germination within live hosts (Figs 1B, 1F, 1J, 1N, 4D and 4J). These observations are consistent with clearly distinct infection patterns (assessed by measuring infection load) caused by the two Bt strains and with Bt679 exhibiting higher pathogenicity as reported previously [35]. Together, our results show that dynamics of Bt247 and Bt679 infection are qualitatively different.

Fig 1. Distinct infection dynamics of Bt247 and Bt679 infection.

Fig 1

TEM pictures of transversal cuts of the C. elegans intestine 2 hours (h), 6 h, 12 h, and 24 h post infection (p.i.) with Bacillus thuringiensis (Bt) Bt247, Bt679 or the non-pathogenic controls Bt407 and E. coli OP50. (A) Worm diagram modified from WormAtlas [37] showing the area of the intestine analyzed by transmission electron microscopy (TEM) for (C-Q). (B) shows the first intestinal ring. (B-Q). Microvilli of the apical membrane are marked throughout and artificially colored in red to point out integrity during infection. S = spores, V = vegetative Bt cells. Scale bar represents 1 μm except for pictures B where it is 2 μm and O where it is 5 μm. The Section delimited by a blue square in panel (A) indicates area shown in pictures (B-N, P-Q).

Fig 4. elt-2 silencing causes decreased intestinal integrity on Bt679 but increased intestinal integrity on Bt247, while pathogen load remains the same as in controls.

Fig 4

Bt load of elt-2(RNAi) and control worms exposed to (A) Bt247 and (B) Bt679. (C-N) TEM pictures of transversal sections of the anterior intestine of elt-2(RNAi) and control worms exposed to different Bt strains. The microvilli of the apical membrane are artificially colored in red to indicate their integrity during infection. Scale bar represents 2 μm in C-H and 1 μm in I-L. White boxes in A-F show area that is zoomed-in in I-N. MV = microvilli, S = Bt spores, V = vegetative Bt cells. See also S2 Fig.

The C. elegans transcriptomic response to Bt247 and Bt679 infection has common and distinct signatures

To understand how C. elegans responds to two pathogenic strains of the same species that vary in virulence factor expression and exhibit distinct infection dynamics, we explored the worm’s transcriptional response to Bt247 and Bt679 across four time points p.i. by mRNA sequencing (Fig 2A). We identified 5477 genes with significant differential expression (DE) between pathogenic Bt and the non-pathogenic control strain Bt407 treatments for at least one of the time points (S1 Table). Importantly, the two control treatments Bt407 and E. coli OP50 showed only little variation to each other (S1 Table), indicating that virulence-associated processes are required to activate the C. elegans response to Bt. We thus focused on the comparison between the pathogenic Bt strains (Bt247 and Bt678) and the non-pathogenic Bt407 (Fig 2A). Using K-means clustering, we found ten distinct groups of genes that exhibited consistent differential expression patterns (Fig 2B). Despite the different Cry toxins produced by Bt247 and Bt679 and despite the clearly distinct infection dynamics, the vast majority of differentially regulated genes (91%) were common between the two strains across the four time points. Clusters 1, 3–7, 9, and 10 include genes either up-regulated (46% of all DE genes) or down-regulated (45% of all DE genes) by infection with both pathogenic strains and thus reflect the common transcriptional response to Bt (Fig 2B, S1 Table).

Fig 2. Bt247 and Bt679 induce common as well as distinct transcriptomic responses in C. elegans.

Fig 2

(A) Infection protocol for the transcriptome analysis. (B) Heatmap representing all significant DE genes upon exposure to either Bt247 or Bt679 compared to the non-pathogenic Bt407 control. K-means clustering yielded ten clusters of co-expressed genes. (C) Top scores of functional enrichment analysis per cluster (p-values are Benjamini corrected). (D) Significantly enriched TF binding motifs.

Importantly, 9% of DE genes are found in cluster 2 (234 genes) and cluster 8 (275 genes) and these clusters define response modules that are distinct between the two Bt strains. Cluster 2 contains genes that are exclusively up-regulated upon Bt247 exposure. The potential effector genes lec-6, known to be required for the response against the PFT Cry6Aa [30] and the lysozyme lys-2, important for resistance against Bt247 [38], were found in this cluster. Cluster 8 contains genes, whose expression was down-regulated at early time points on both Bt247 and Bt679 but up-regulated only upon exposure to Bt247 at later time points. In this cluster, we found the necrosis terminal aspartic protease gene asp-1, which mediates susceptibility to the PFT Cry6Aa [39], and the saposin-like protein encoding gene spp-8, a putative immune effector (Fig 2B, S1 Table). Genes with immunity and lipid metabolism annotation terms were significantly enriched in these two strain-specific clusters (Fig 2C, S2 Table).

To identify transcription factor (TF) binding sites that govern the common and specific gene expression changes upon Bt infection, we used a motif enrichment analysis of promoter regions for each of the gene expression clusters. A GATA motif was significantly overrepresented in the promoter regions of genes from five clusters (clusters 1–3, 7, 8), thus including the distinct response modules (Fig 2D). The binding motif of the AP-1 TF complex (JUN-1/FOS-1) was additionally enriched in clusters 1 and 3 (Fig 2D), containing genes commonly up-regulated early (Fig 2B). GATA TFs have been described as central regulators of general defense responses against pathogens in the C. elegans intestine [17,4042]. The C. elegans JNK-like MAPK pathway, which can activate AP-1-dependent transcription, is known to regulate defenses against the Bt crystal PFT Cry5B (not expressed by either Bt247 or Bt679) as well as abiotic stresses like cadmium [27]. We conclude that GATA TFs and the JNK-like MAPK pathway represent interesting candidates for regulating distinct and common responses to strains Bt247 and Bt679, respectively.

jun-1 mediates a common, while elt-2 mediates a distinct response to Bt247 and Bt679

To further characterize the common and distinct response to Bt247 and Bt679 infection, we initially tested if the AP-1(JUN-1/FOS-1) TF complex is required for resistance to both Bt strains. The survival of jun-1(gk551) knockout mutants was assessed upon exposure to different Bt247 and Bt679 spore dilutions at 24 h p.i. (Fig 3A and 3B). Here and below, our survival data are presented as survival curves (Fig 3A and 3D), but also as heatmaps (Fig 3E), to facilitate the comparison of results between different knockout mutants or RNAi treatments and highlight variation across technical and biological replicates. We found that jun-1(gk551) mutants are highly susceptible to both Bt strains (Fig 3A, 3B and 3E), suggesting that JUN-1 and the AP-1 complex are required for the common C. elegans response to Bt and Bt-derived PFTs, extending on their known role in protecting against Cry5B [27].

Fig 3. jun-1 mutants are highly susceptible to both Bt strains, while elt-2 silencing decreased survival on Bt679 but increased survival on Bt247.

Fig 3

Survival of jun-1(gk551) mutant and wildtype N2 animals 24 h p.i. with (A) Bt247 and (B) Bt679. Survival of elt-2(RNAi) and RNAi control worms 24 h p.i. with (C) Bt247 and (D) Bt679. Each line represents proportion survival across different concentrations of Bt spores diluted in E. coli OP50. We chose a dose range allowing to have approximately between 95% and 5% survival from the lowest to the highest concentration of the corresponding wildtype N2 control. Control worms are represented by continuous lines in light red for Bt679 and in light blue for Bt247. The difference of area under the survival curve (AUC) is shaded in purple when the mutant/RNAi worms have lower survival rate than the controls and in orange when the mutant/RNAi worms have a higher survival rate than the controls. Mean and standard error of the mean (SEM) are shown, N = 5 plates with approximately 30 worms each. GLM of the binomial family was fitted (see supplemental methods for model), followed by a Tukey HSD Test, where mutant or knockdown worm strains were compared to control strains. Plus-signs show significant differences including all Bt concentrations between mutant and N2 (A, B), asterisks show significant differences between RNAi treatment and empty vector control (C, D). *** or +++ indicate p < 0.001, Bonferroni adjusted. Results are representative of at least two independent runs. (E) Heatmap representing the difference of the AUC of the mutant/RNAi worms versus the average of the wildtype N2/N2 empty vector controls from the same run (i.e., biological replicate). Purple and orange colors (as in shading of A-D) indicate the value of AUC difference (see scale bar at the bottom). Bars represent technical replicates. Two runs are shown. elt-2(RNAi) was always performed from the L1/L2 larval stage onwards. Statistics as in A-D. Significant differences between all treatment replicates from controls are indicated by an asterisk per run. Results shown in A-D correspond to run I represented in the heat maps of E. (F) elt-2(RNAi) efficiently depletes ELT-2 protein levels. Western blot analysis of worm lysates from elt-2(RNAi) (+) and control (-) worms 6 h p.i. with Bt247 or Bt679. Upper panel, anti-ELT-2. Lower panel, anti-actin as loading control. (G) The opposite elt-2(RNAi) survival phenotype is not determined by elt-2 function during development. Heatmaps show difference in survival 24 h p.i. between wildtype N2 empty vector worms and elt-2(RNAi) worms, with RNAi treatment starting from the L4 larval stage. Survival of three-day old adults was assessed. Data represented in heatmap and statistics as in A-D. See also S1 Fig.

As the GATA motif was enriched in the gene clusters with differential expression towards Bt247 and Bt679, we subsequently assessed whether a GATA TF could account for strain-specific responses. Three C. elegans zinc-finger GATA-type TFs bind to GATA motifs and are active in the adult intestine: ELT-2, ELT-4, and ELT-7 [43]. ELT-4 is believed to be non-functional [44], while ELT-2 and ELT-7 have a synergistic action in endoderm differentiation during development [45,46]. ELT-2 is a homolog of Drosophila SERPENT [47] and vertebrate GATA4-6 and likely the predominant GATA TF for intestinal gene regulation during development and also in adult C. elegans [17,41,43,48]. To test the involvement of the intestinal GATA TFs in the response to Bt247 and Bt679 infection, we analyzed the survival rate of elt-7(ok835) and elt-7(tm840) knockout mutant worms (S1C Fig) and of worms, in which elt-2 expression was silenced by RNAi (elt-2(RNAi), efficient knockdown shown in Fig 3F). The survival assays of elt-7(ok835) and elt-7(tm840) mutants yielded inconclusive results, as the two mutant alleles affected survival in opposite ways (S1C Fig). In contrast, the results for RNAi-mediating silencing of elt-2 were highly consistent and produced a striking phenotype: elt-2(RNAi) resulted in lower worm survival after Bt679 infection (Fig 3D and 3E), but significantly higher survival after Bt247 infection (Fig 3C and 3E). Importantly, elt-2(RNAi) did not affect worm survival on the non-pathogenic Bt407 (Fig 3E), confirming that the animals are not generally sick [40,42]. The opposite elt-2(RNAi) survival phenotypes after infection with Bt247 and Bt679 were still observed when RNAi was started from the L4 stage onwards (Fig 3G) and pathogen cultures had identical virulence levels (S1B Fig compared to S1A Fig). The results are thus unlikely due to anomalous intestinal development in elt-2(RNAi) worms or a quantitative difference in Bt virulence.

Together, our results show that the C. elegans response to Bt247 and Bt679 has a common component (Figs 2B, 3A and 3B), but also a clear Bt strain-specific component evidenced by the distinct effects of elt-2(RNAi) on survival rate after infection (Fig 3C and 3D). While our Bt679 results support the idea of a key regulatory function of ELT-2 in C. elegans intestinal immune defense [17,4042,49], the Bt247 results are unexpected as elt-2 silencing reduces C. elegans susceptibility to this particular pathogen. This prompted us to further investigate the effects of elt-2 knock-down on Bt679 and Bt247 infection processes.

elt-2 RNAi leads to higher intestinal tissue integrity on Bt247 and has the opposite effect on Bt679

We sought to better understand the intriguing contrasting effects of elt-2(RNAi) on survival of Bt247 and Bt679 infected worms and to gain insight into the underlying infection processes. For this we assessed pathogen load (Fig 4A and 4B) and intestinal integrity (Fig 4C–4N and S2) in infected elt-2(RNAi) and control (empty vector) worms. Previous work demonstrated that active elt-2 can reduce bacterial load [42], presumably because it positively regulates expression of intestinal infection response genes [47]. We now found that Bt679 pathogen load of elt-2(RNAi) worms indeed showed a statistical trend (0.1 > p > 0.05) to be higher than that of the controls (Fig 4B). More importantly, however, Bt247 pathogen load of elt-2(RNAi) worms did not differ at all from controls (p = 0.2; Fig 4A). elt-2(RNAi) worms thus show significantly higher survival rate on Bt247 (Fig 3C and 3E), despite a high pathogen load (Fig 4A).

To assess the integrity of the intestinal epithelium of elt-2(RNAi) worms on Bt247 and Bt679, we performed TEM of cross sections of the anterior intestine 12 h p.i. We found that intestinal damage is generally inversely proportional to worm survival rate (Fig 4C–4N), especially for worms infected with Bt247 (Fig 4D, 4G, 4J and 4M). elt-2(RNAi) worms infected with Bt679 showed exacerbated loss of intestinal brush border integrity (Fig 4H–4N) compared to empty vector controls (Fig 4E and 4K). In contrast, although elt-2(RNAi) worms infected with Bt247 also showed damage of the intestinal epithelium (distension of the intestinal lumen, shortening of the microvilli, and gaps in the intestinal brush border; (Fig 4G and 4M), signs of damage were less pronounced than in control worms (Fig 4D and 4J). We validated and confirmed our findings by studying intestinal epithelial integrity of elt-2(RNAi)-treated worms in the transgenic fluorescent reporter strain BJ49, which contains the fluorescently tagged intermediate filament protein IFB-2::CFP (S2A–S2P Fig) and by using the “smurf” assay (S2Q–S2S Fig).

Collectively, our results suggest that the mechanism through which elt-2 RNAi increases host survival rate after infection with Bt247 may involve enhanced tolerance to pathogen infection, which we define as the ability to limit the damage caused by a given pathogen burden [5053]. This response is distinct from resistance, which we define to be the ability to limit pathogen burden (following [54]), usually as a consequence of immune effector activity. elt-2(RNAi) worms may be tolerant to Bt247 infection, since they show a high survival rate and reduced tissue damage despite high pathogen load. On the other hand, elt-2(RNAi) worms are highly susceptible to Bt679 infection likely due to reduced resistance, as further discussed below.

It is tempting to speculate that the resistance vs. tolerance strategy possibly employed by the host to defend itself against Bt679 and Bt247, respectively, is advantageous in the context of the distinct infection dynamics, which we observed for the two BT strains. Since Bt679 rapidly colonizes the C. elegans gut (displaying early spore germination followed by massive multiplication of vegetative cells (Figs 1C, 1G, 1K, 1O, 4E and 4K)), an immediate antimicrobial response to quickly eliminate the pathogen might be the only chance of survival. Interestingly, Wang et al. observed that C. elegans surviving Bt679 infection show low or absent infection and proposed that an immediate activation of immune response might yield surviving hosts with cleared infections [35]. Bt247, on the other hand, displays a gradual accumulation of spores, but apparently no germination within live hosts (Figs 1B, 1F, 1J and 1N, 4D and 4J). In this case, protection against the action of the spore-associated Cry toxins by e.g. fortification of the intestinal barrier might be more advantageous for host survival than pathogen control. Indeed, an epidemiological model proposed by Restif and Koella predicts that different conditions can favor resistance or tolerance: In particular, low virulence and high infection rate should favor host tolerance, whereas high virulence and low infection rate should favor resistance [55], in general consistent with our findings.

It is striking that inactivation of a single TF gene may lead to resistance-defective animals on one Bt strain and to potentially tolerance-enhanced animals on the other Bt strain. Interestingly, in Drosophila melanogaster, resistance and tolerance could be increased or decreased by a single mutation in CG3066, a gene encoding a protease active in the melanization cascade, dependent on the pathogen species [56].

In the following sections we initiated further experiments to elucidate genes involved in elt-2(RNAi)-mediated susceptibility to Bt679 and high survival on Bt247.

elt-2 RNAi leads to reduced survival rate on Bt679 likely through reduction of resistance

We next assessed in more detail how elt-2(RNAi) causes reduced resistance to Bt679 infection. We first evaluated the interaction between elt-2 and the p38 MAPK pathway, because (i) the p38 pathway is known to coordinate C. elegans resistance to a variety of pathogens [57] and also exposure to the Bt PFTs Cry5B and Cry21A [23,24], (ii) it cooperates with ELT-2 in the response against Pseudomonas aeruginosa and Salmonella enterica and the subsequent recovery from these infections [47,58], and (iii) the specific response clusters 2 and 8 (Fig 2B) were enriched for the GATA binding motif (Fig 2D) and also p38 pathway targets (S3 Table). We found that the p38 MAPK mutant pmk-1(km25) and the p38 MAPKK mutant sek-1(km4) were indeed highly susceptible to Bt679 (Fig 5A). However, they surprisingly survived infection with Bt247 as well as wildtype worms (Fig 5A). pmk-1(km25);elt-2(RNAi) animals displayed a higher survival rate compared to elt-2(RNAi) and control animals after Bt247 infection (Fig 5A, S3A Fig). pmk-1(km25);elt-2(RNAi) animals were, however, significantly more susceptible than elt-2(RNAi) and pmk-1(km25) mutant worms alone after Bt679 infection, indicating that elt-2 acts in parallel to the p38 MAPK pathway in mediating resistance to Bt679 (Fig 5A, S3B Fig), possibly by regulating the expression of complementary sets of immune effector genes. We identified two candidate Bt679-specific effector genes in our transcriptome data and tested if they play a role in the specific interaction with Bt679: The saposin-like protein encoding spp-8 and the superoxide dismutase gene sod-3 were indeed specifically required for resistance to Bt679, but did not affect survival on Bt247 (Fig 5B). We conclude that the p38 MAPK pathway is required for survival on Bt679 but is dispensable for defense against Bt247. These results thus confirm that part of the C. elegans response to Bt247 and Bt679 infection is distinct and relies on different intracellular signaling pathways.

Fig 5. The p38 MAPK pathway and putative effector genes spp-8 and sod-3 are specifically required for defense against Bt679 infection.

Fig 5

Difference in survival at 24 h p.i. between the N2 control and (A) p38 MAPK pmk-1(km25) and MAPKK sek-1(km4) mutant exposed to Bt247 or Bt679, and epistasis analysis following elt-2(RNAi), (B) the putative effector saposin-like protein-encoding gene mutant spp-8(ok3758) and the superoxide dismutase mutant sod-3(gk235). spp-8 and sod-3 are specifically required for resistance against Bt679, but not Bt247. Data represented in heatmaps and statistics as in Fig 3E. Triangles indicate significant difference compared to elt-2(RNAi). In A, worms were grown on RNAi E. coli HT115 plates until L4 larval stage when worms were exposed to Bt. OP50 above a run indicates that the worms were grown on NGM plates seeded with E. coli OP50 (absence of RNAi treatment). See also S3 and S4 Figs.

Bt247 and Bt679, albeit being two strains of the same pathogen species, produce different Cry toxins, which are essential virulence factors of these two strains (S4E and S4H Fig) [31,32]. As C. elegans is capable of mounting distinct responses to these Bt strains in an elt-2-dependent manner, we asked if elt-2 is also required for mounting distinct responses to individual Bt247 and Bt679 Cry toxins (S4 Fig). Cry6Ba is the only crystal protein produced by Bt247 (S4B and S4C Fig) and its depletion was shown to abolish Bt247 toxicity to nematodes (S4E Fig) [31]. We purified Cry6Ba from Bt247 cultures, but, intriguingly, the Cry6Ba toxin alone was unable to kill the host, possibly indicating that other yet unknown virulence factors are involved in Bt247 toxicity towards nematodes (S4F Fig). Indeed, Cry6Ba was previously shown to have coleoptericidal activity [59], but only limited nematocidal activity compared to Cry6Aa [60]. Also, Cry6 toxins are hemolysin E (HlyE)-like toxins (also known as Cytolysins A) and there are numerous examples of synergistic activities between cytolysins and other virulence factors (e.g., [61]; reviewed in [62]). In contrast to purified Cry6Ba, C. elegans was killed by the purified Bt679 toxins mixture, which includes the two nematocidal toxins Cry21Aa and Cry14Aa (S4A Fig). elt-2(RNAi) worms were more sensitive to the Bt679 toxin mixture than control worms (S4G Fig), pointing to elt-2 being required for defense against Bt679 Cry toxins. To assess the separate effects of the two nematocidal Cry21Aa and Cry14Aa toxins, we took advantage of a non-pathogenic Bt679 Cry- strain that lacked these toxins [32] and re-introduced them individually. Strikingly, elt-2(RNAi) worms were susceptible to Bt679 spores, which produce soluble Cry21Aa after germination, but not to those producing Cry14Aa (S4H Fig), suggesting that elt-2 is only required for the C. elegans defense response to Cry21Aa. Our results thus extend the previous findings that regulators and mediators of the C. elegans response vary between Cry toxins [27,29,30,39,63]. We conclude that the level of specificity in the interaction between the host and pathogenic Bt is to some extent driven by individual Bt virulence factors.

elt-2 RNAi leads to increased survival rate after Bt247 infection through multiple possible mechanisms

Our results on the role of elt-2 in defense against Bt679 is in line with previously published work on other pathogens, i.e. elt-2 regulates the expression of immune effector genes and is thus required for resistance to pathogen infection [40,42,47]. In contrast, elt-2(RNAi)-mediated increase in survival rate after infection, as we observed for Bt247, has not been reported before. Also, the high survival of Bt247 infected worms is unique among several Bt strains we tested (S4D Fig). There are several possible explanations for the observed high survival of elt-2(RNAi) worms on Bt247. First, ELT-2 might positively regulate the expression of genes that are required for infection and thus susceptibility to Bt247, encoding e.g. the toxin-binding receptor. Several individual host factors that are required for susceptibility to toxins Cry5B, Cry14A and Cry6A are known [39,63]. We thus tested if these host factors are involved in elt-2(RNAi) mediated high survival on Bt247. We could exclude an involvement of the Bt-toxin resistant (bre) genes required for synthesis of the Cry5B glycosphingolipid receptor [63], given that bre and other glycosylation-deficient mutants were susceptible to Bt679 and Bt247 infection (Fig 6A). We could also exclude involvement of the necrosis pathway (Fig 6B), for which the central aspartic protease ASP-1 was previously shown to physically interact and confer susceptibility to Cry6Aa [39]. The necrosis-deficient mutant asp-1(tm666) showed reduced survival on Bt247 in one out of five runs only (Fig 6B). Also, for mutants deficient in additional members of the necrosis pathway vha-12(ok821) and itr-1(sa73), we were not able to find consistent results that would suggest that the necrosis pathway is involved in the response to Bt247 (Fig 6B). In this context, it is important to emphasize that our assay usually produces highly consistent results across independent biological replicates (see for example Figs 3 and 5). If in other cases, the results are variable and not consistently negative, then this indicates that the respective gene can have at least a minor effect on the considered phenotype–in contrast to clear evidence for an absence of an effect.

Fig 6. Specific responses to Bt247 and Bt679 do not involve the bre genes or the necrosis pathway.

Fig 6

(A) A binary score considered resistance of glycosylation-deficient mutants to pathogen exposure as >70% survival of ~300 worms on plate. N = 5. Each bar represents the score of a single plate. Our results show that glycosylation-deficient mutants are susceptible to Bt679 and Bt247. (B) Difference in survival between the N2 control and the knockout mutants of the: terminal necrosis protein aspartase asp-1(tm666), inositol triphosphate receptor ion channel itr-1(sa73), and vacuolar proton translocating ATPase vha-12(ok821). Asterisks show significant differences between mutant and the wildtype N2 control. Infection of Bt247 led to inconsistent survival phenotypes of the asp-1(tm666) mutant animals, including significantly higher survival, significantly lower survival, and no survival difference in separate runs of the experiment. Similar levels of variation were also found upon Bt247 infection of asp-1(tm666) mutant animals, in which elt-2 was inactivated by RNAi. The necrosis-deficient mutant of another pathway component, itr-1(sa73), had significantly higher survival rate on Bt679 and lower survival rate on Bt247 compared to control worms. The necrosis-deficient mutant of yet an additional pathway component, vha-12(ok821), had higher survival rate on Bt247 compared to control worms and had inconsistent survival phenotypes on Bt679. Since knockout mutants of different necrosis pathway components show different survival phenotypes upon infection, we conclude that deficiency in necrosis is unlikely to have a strong effect on tolerance to Bt247. The data represented in the heatmap and statistics as in Fig 3E. In (B) worms were grown on RNAi E. coli HT115 plates or on NGM plates seeded with E. coli OP50 (indicated by ‘OP50’ above a run).

We further tested the involvement of sterility, considering that sterile mutants are often resistant to pathogen infection [6466] and that elt-2(RNAi) reduces worm fecundity and fertility [43]. We found that the sterile rrf-3(b26), glp-1(ar202), and glp-1(bn18) (S5A and S5B Fig) mutants had higher survival than wildtype after infection with both Bt strains and that the additional knockdown of elt-2 further increased survival on Bt247 and displayed higher survival rate than elt-2(RNAi) worms alone on Bt679 (S5B Fig). We thus conclude that the increased survival rate of elt-2(RNAi) worms infected with Bt247 does not involve the bre genes and the necrosis pathway, while sterility could influence but not fully explain the increased survival rate on Bt247 and shows no strain-specific effects on survival rate. It is still possible that the increased survival rate of elt-2(RNAi) worms infected with Bt247 is due to a down-regulation of the unknown intestinal receptor of Cry6Ba by the elt-2(RNAi) treatment, since elt-2 is a global regulator of intestinal gene expression [48]. However, unlike bre mutants that are completely resistant to Cry toxin exposure and do not show any intestinal tissue damage [63,67], elt-2(RNAi) worms infected with Bt247 show intestinal damage, despite highly efficient depletion of ELT-2 by the RNAi treatment (Figs 3F and 4M) (S2I, S2J and S2S Fig). These results suggest that in elt-2(RNAi) worms the Bt247 toxin conserves, at least to some extent, the capacity to cause damage and therefore that the toxin receptor is, at least to some extent, still expressed. This possibility can only be tested in more detail once the receptor of the Bt247 toxin will be identified.

Based on the previous set of results, we hypothesized that the effect of elt-2(RNAi) is multifactorial and ultimately leads to enhanced tolerance to Bt247 infection, as discussed above. In C. elegans, most studies on pathogen defense mechanisms do not differentiate between resistance and tolerance, with a few exceptions [6870]. As a result, little is known about the underlying genetics of tolerance to infection in C. elegans. We thus initiated further experiments to elucidate genes possibly involved in tolerance to Bt247.

elt-2 regulates putative detoxification and lipid metabolism enzymes on Bt247

To further explore the molecular processes involved in the elt-2-mediated increase in survival rate after Bt247 infection, we performed an additional transcriptome analysis with Bt-infected elt-2(RNAi) worms by mRNA sequencing (S4 Table). In total, the expression of 6180 genes was affected by elt-2(RNAi) (Fig 7A and 7B). The strain-specific DE patterns on Bt247 and Bt679 (clusters 2 and 8 uncovered in the first transcriptome data set, Fig 2B) disappeared upon elt-2 knockdown and the expression changes on Bt247 resembled more patterns on Bt679 (red boxes in Fig 7A). Together with our genetic analyses, these data strongly suggest that the strain-specific gene expression changes are mainly dependent on ELT-2.

Fig 7. Detailed transcriptional and functional analysis of elt-2 mediated tolerance to Bt247.

Fig 7

(A) DE heatmap of a combined analysis of the first transcriptome dataset in wildtype N2 animals (first two columns of each pathogen strain section; subset of data from Fig 2) and a second additional transcriptome data set using elt-2(RNAi) worms and empty vector controls 6 h and 12 h p.i. with Bt247, Bt679 or the non-pathogenic Bt407. Clusters including genes commonly up- and down-regulated on all bacteria are highlighted. (B) Heatmap of the same data, highlighting DE between elt-2(RNAi) and empty vector controls on each Bt strain. (C) Gene ontology (GO) functional enrichment analysis of genes up- and down-regulated (as indicated) when comparing elt-2(RNAi) worms with controls, both exposed to Bt247. For both gene sets, the GO terms metabolism, transcription, detoxification and antimicrobial were among the most significantly enriched functions. Examples of genes supporting these enriched terms are shown. (D) Survival of the nuclear hormone receptor mutants nhr-193(tm4479) and nhr-99(gk758), exposed to Bt247 and Bt679 and epistasis analysis following elt-2(RNAi). Heatmaps and statistics as in Fig 3E. Triangles indicate a significant difference compared to elt-2(RNAi). (E) Expression pattern of the transcriptional reporter strain nhr-193p::GFP (MY1094) in empty vector control worms and elt-2(RNAi) L4 worms. Scale bar represents 50 μm. See also S6 Fig.

We next focused on the genes commonly regulated by elt-2 on all three Bt treatments (Fig 7B). We found 507 genes (8% DE genes) that were down-regulated in elt-2(RNAi) animals on all bacteria, representing the core set of genes that require elt-2 for transcriptional activation (Fig 7B, cluster 6). Surprisingly, 698 DE genes (11% DE genes) were up-regulated in elt-2(RNAi) animals on all bacteria. For these genes, other TFs may overcompensate for loss of ELT-2, similar to a previously described class of genes up-regulated in the elt-2 mutant at the first larval stage [46] (Fig 7B, cluster 9).

The genes that specifically respond to elt-2(RNAi) upon Bt247 infection (red box in Fig 7B, S5 Table) included 1106 down-regulated and 1578 up-regulated genes (S4 Table). The down-regulated gene set was significantly enriched for genes putatively involved in lipid metabolism, detoxification, xenobiotic metabolism, and also genes encoding C-type lectins and collagens (Fig 7C, S5 Table). Since their down-regulation is associated with increased survival rate after Bt247 infection and possibly with tolerance to infection, activity of these processes and genes may be required by some part of the Bt infection process and thus their inactivation prevents Bt-mediated killing. The down-regulated category of lipid metabolism includes genes predicted to function in sphingolipid synthesis and breakdown [71], such as the ceramide glucosyl transferase genes cgt-1 and cgt-2, the glycosylceramidases gba-1, gba-2, and gba-4, the sphingomyelin phosphodiesterase asm-2, and the acylsphingosine amidohydrolase asah-1. Notably, CGT-1, CGT-2, and CGT-3 were previously shown to add carbohydrate groups to the sphingolipid ceramide [72], yielding glucosylceramide, which can be further glucosylated by BRE-2, BRE-3, BRE-4, and BRE-5, leading to glycosylated sphingolipids, which are known targets of the Bt toxins Cry5B and Cry14A [63]. As bre mutants are susceptible to Bt247 (Fig 6A), we speculate that glucosylceramides also act as precursors for other glycosphingolipids that may serve as receptors for Cry6B. Moreover, the down-regulated gene set included two transcriptional regulators of C. elegans fatty acid metabolism, the transcriptional mediator subunit MDT-15 and the nuclear hormone receptor NHR-80 [73], indicating a role of fatty acid metabolism in Bt247 tolerance (see below).

The set of up-regulated genes was similarly enriched for detoxification and lipid metabolism, although based on different genes than those in the down-regulated set (Fig 7C, S5 Table). The “lipid metabolism” category contained several genes involved in fatty acid desaturation and elongation, including the desaturase enzyme genes fat-1, fat-2, fat-3, and fat-4, and the fatty acyl elongase elo-2. Since their up-regulation correlated with increased survival, we propose that alterations in fatty acid content and abundance of poly-unsaturated fatty acids (PUFAs) might restrict the effects of Bt247 infection. PUFAs play important roles in membrane structure and function and are precursors for a variety of different signaling molecules and ligands for transcription factors [74]. Additional work will be required to evaluate whether and how exactly fatty acid composition and PUFAs can influence a defense trait like tolerance.

elt-2 RNAi-mediated high survival on Bt247 is influenced by the nuclear hormone receptors NHR-193 and NHR-99

To explore the possible role of fatty acid metabolism in increased survival rate after infection with Bt247 and possibly tolerance, we focused on potential regulators such as nuclear hormone receptors (NHRs) [75]. Interestingly, the Bt247-exclusive responsive genes in cluster 2 from our first transcriptome data set (Fig 2B) were significantly enriched for nhr-8 targets (S3 Table). Moreover, nhr-8, nhr-99, and nhr-193 were all part of cluster 2 and nhr-193 expression was down-regulated upon elt-2(RNAi) (Fig 7D, S4 Table). NHR-8 regulates genes required for elongation and desaturation of fatty acids and also the expression of xenobiotic detoxification genes [76,77], while the function of NHR-99 and NHR-193 is unknown. We assessed the potential link between ELT-2 and these NHRs in the context of Bt infection and first exposed knockout mutants of these genes to Bt247 and Bt679. While there was no effect for nhr-99(gk758) and nhr-193(tm4479), nhr-8(ok186) worms survived significantly better than wildtype N2 on both Bt strains (Fig 7D and S6 Fig). Thus, NHR-8 contributes to the general but not to the strain-specific Bt response. nhr-8(ok186);elt-2(RNAi) worms did not vary in survival to the elt-2(RNAi) control (S6 Fig), while both nhr-99(gk758);elt-2(RNAi) and nhr-193(tm4479);elt-2(RNAi) worms had lower survival rate than elt-2(RNAi) worms on Bt247 (Fig 7D). Importantly, the knockout of nhr-99 and nhr-193 had no significant effect on the survival rate of elt-2(RNAi) worms after Bt679 infection, supporting their specific role towards Bt247 only (Fig 7D). Using a transcriptional GFP reporter for nhr-193, we found strong, elt-2-dependent expression in the cytoplasm and especially nuclei of intestinal cells (Fig 7E), consistent with a function in the worm’s gut. Altogether, our results suggest that elt-2(RNAi)-mediated increase in survival rate after Bt247 infection is partially dependent on NHR-99 and NHR-193.

A model of elt-2 mediated distinct immune responses to Bt247 and Bt679

We used the nematode C. elegans as a model to characterize common and distinct responses against different strains of the same pathogen species. We were interested in understanding in how far differences in virulence factor expression and infection dynamics, caused by closely related pathogens, could elicit distinct defense responses in an invertebrate host. We combined several transcriptome datasets with functional genetic analysis of candidate genes and identified the GATA TF ELT-2 as central regulator of pathogen strain-specific responses. Surprisingly, silencing of elt-2 caused contrasting effects towards the two tested pathogenic Bt strains. elt-2 was previously proposed as the central general regulator of defense responses against intestinal pathogens [17,41], implying that it mediates similar responses to a large diversity of pathogen taxa. Yet, it was unknown that it could additionally be involved in highly fine-tuned responses to two strains of the same pathogen species. In particular, elt-2 is required for C. elegans resistance to Bt679, most likely through activating specific effector proteins such as SPP-8 and SOD-3 and acting in parallel to the p38 MAPK pathway (Fig 8). In contrast, elt-2 inactivation causes increased survival rate after infection with Bt247 (Fig 8), which is characterized by reduced intestinal damage despite a high pathogen burden. elt-2(RNAi) thus seems to have an impact on tolerance, rather than resistance to Bt247 infection. The elt-2(RNAi)-mediated response to Bt247 infection is completely independent of the p38 MAPK pathway, which to date has been associated with resistance to multiple pathogen threats [78,79]. Moreover, elt-2(RNAi)-mediated increase in survival rate after Bt247 infection seems to be multifactorial. Gene expression analysis points to a possible involvement of multiple candidate mechanisms such as detoxification and lipid metabolism, which need to be validated in future studies. Further, we show that elt-2(RNAi) mediated survival on Bt247 partially depends on two additional TFs, encoded by the nuclear hormone receptor genes nhr-99 and nhr-193. Overall, our study provides new insight into the molecular mechanisms underlying distinct defense responses to infection with two different pathogen strains of the same species in an invertebrate. As these pathogen strains produce distinct virulence factors that however have a similar mode of causing damage in that they form pores in the membrane, our study further highlights an unexpected complexity of invertebrate defense strategies against pathogens. We anticipate that our findings may stimulate similar studies on pathogen-strain-specific host responses, which are so far largely unexplored in other invertebrate taxa.

Fig 8. Model of the host genes and processes involved in Bt strain-specific interaction with C. elegans.

Fig 8

ELT-2 plays a central role in mediating distinct responses to Bt247 (blue background) and Bt679 (red background), as shown by the differential regulation of known ELT-2 targets by Bt247 and Bt679 exposure and the disappearance of this strain-specific DE pattern upon elt-2 knockdown in our transcriptome analyses. Other transcription factors such as NHRs appear to interact with elt-2 to hone the transcriptional response to a specific pathogen. Please note that while only strain-specific response pathways are shown here, the responses to the two Bt strains are not completely distinct, common response pathways like the one mediated by jun-1 may interact or act in parallel to ELT-2. The differential activation of the ELT-2 targets must be initiated by an upstream sensor, which is represented here by question marks and still needs to be identified in future work. Arrows represent positive influence in the function of a given gene or process, bars represent a negative influence and double dashed lines represent genetic interaction between genes or biological processes.

Materials and methods

C. elegans and bacterial strains

Worm strains were maintained on nematode growth medium (NGM) plates at 20°C and fed with E. coli OP50 as described in [80]. Strains used and the sources from which they were obtained are listed in S6 Table. Bt spore solutions were obtained as previously described [22,81]. Briefly, we thawed frozen stocks on Luria-Bertani (LB) plates, which were incubated overnight at 25°C. Sterile disposable inoculation loops (Roth) were used to pick a single colony of Bt407, or multiple colonies of Bt679 and Bt247 (to ensure that a colony carrying the Cry toxin-encoding plasmids was selected), to inoculate 1000 mL of sterile liquid Bt medium (Bacto-peptone (Sigma)(7.5 g/L), glucose (5.56 mM), KH2PO4 (22.06 mM), H2HPO4 (22.99 mM), pH adjusted 7.2) supplemented with 5 mL filter-sterilized salt solution (MgSO4.7H2O (100 mM), MnSO4.H2O (2.37 mM), ZnSO4.7H2O (9.76 mM), FeSO4.7H2O (14.39 mM)) and 1250 μL CaCl2 (1M). Cultures were incubated at 28°C with shaking for seven days. After four days of incubation the cultures were supplemented with additional 5 mL salt solution (as previously described) and 1250 μL CaCl2 (1M). The described culturing method is used to induce sporulation. Cultures containing a spore-toxin-particle mix were subsequently harvested by centrifugation in 50 mL Falcon tubes (SARSTEDT) for 10 min at 4000 rpm. Supernatants were removed, pellets were resuspended in Phosphate Buffered Saline (PBS) and particle concentrations were assessed with the Neubauer improved counting chamber. Culture concentrations ranged between 109–2 x 1010 particles/mL for strains Bt247, Bt247 Cry-, Bt679, Bt679 Cry- (RFP), Bt679 Cry- (Cry14Aa) and Bt679 Cry- (Cry21Aa) and between 103–104 particles/mL for Bt407. The resulting cultures were aliquoted in 1.5 mL Eppendorf tubes and stored at -20°C for further use.

Bt survival assays

Bt survival assays were performed as previously described [18]. Briefly, to assess survival of wildtype (N2) and mutant strains, worm populations with many eggs were washed off plates with M9 buffer (KH2PO4 (22 mM), Na2HPO4 x 2 H2O (33.7 mM), NaCl (85.6 mM), supplemented with 1 mL MgSO4 (1M) after autoclaving) and synchronized by bleaching: 4 mL washed worms/eggs in M9 were mixed in a 15 mL Falcon tube (SARSTEDT) with 1 mL of a 1:1 solution of NaOH (5M) and NaClO (12%) for 5 min with vortexing and inverting. Bleaching was stopped by centrifuging for 1 min at 3500 rpm, supernatant was discarded, and pellet was washed three times with 5 mL M9 buffer. Only eggs survived the treatment. An extra synchronization step included incubation of bleached eggs in M9 buffer overnight in a horizontal shaker at 20°C until all eggs had hatched. Hatched larvae were raised on 9 cm diameter NGM plates seeded with 700 μL of an overnight liquid culture of E. coli OP50 in LB broth medium. At the L4 larval stage approximately 30 worms per plate were transferred by pipetting to 6 cm diameter peptone-free NGM (PFM) plates inoculated with either 75 or 100 μl of Bt spore solutions mixed with E. coli OP50 adjusted to an optical density (OD600) of 5 with PBS buffer. Different dilutions of pathogenic Bt spores were tested to produce dose-response curves. Non-nematocidal Bt strain Bt407 Cry- (Bt407) lacks pore-forming toxins and was used as infection treatment control, but only at the single highest concentration in which pathogenic Bt were tested. The infection plates were left to dry overnight at 20°C. Alive and dead worms were assessed by reaction to gentle touch with a platinum wire at 24 h p.i. Analysis of survival experiments was done using R [82] and final preparation for visualization was done using Inkscape (http://www.inkscape.org/). The model fitted was glm(formula = cbind(Worms Alive, Worms Dead) ~ worm treatment (RNAi) and/or worm strain*Bt concentration, family = binomial). Statistical significance of treatment effects was assessed post hoc using Tukey HSD test and p-values were Bonferroni corrected.

RNA interference

For elt-2 knockdown, worms were fed with the X-5I11 E. coli HT115 RNAi clone from the Source BioScience Ahringer RNAi library [83]. E. coli HT115 containing L4440 RNAi empty vector were used as negative control. As positive control of gene knockdown a subset of worms was fed in parallel with Ahringer E. coli HT115 RNAi clones I-1A05 bli-3 (multiple blisters), IV-6K06 unc-22 (twitching), and II-7O15 plc-3 (severely reduced egg laying). 300 synchronized L1 larvae were placed on 6 cm plates seeded with 100 μl of concentrated RNAi bacteria for 48 hours. Survival analysis was done as described above. ELT-2 is a major regulator of intestinal development. To verify that the changes in the survival phenotype of elt-2(RNAi) worms exposed to pathogenic Bt were not exclusively due to an abnormal development we also performed elt-2 knockdown starting at the L4 larval stage for 48 hours. Three-day control and elt-2(RNAi) adult worms were exposed to Bt and survival was scored as above.

Bt exposure, RNA isolation and differential expression analysis

Two transcriptomic studies were carried out. For the first transcriptomic study N2 worms at the L4 larval stage were exposed to Bt as described before in 9 cm diameter PFM plates inoculated with 250 μl of Bt spore solution diluted with E. coli OP50 OD600 5. Worms were exposed to an equal dose of spores of the pathogenic strains Bt247 (leading to 88% survival 24 h p.i.) and Bt679 (leading to 50% survival 24 h p.i.) and of the non-pathogenic controls Bt407 and E. coli OP50. After 2 h, 6 h, 12 h and 24 h p.i worms were washed off the plates using PBS supplemented with Tween-20 to a final concentration of 0,3% (PBST). Worms were centrifuged and washed with PBST buffer 3 times and then transferred to TRIzol lysis Reagent™ (Invitrogen). Worms were cyclically thawed and frozen five times using liquid nitrogen and a heating block at 37°C to allow the TRIzol reagent to enter the cells and better preserve the RNA. RNA was extracted using the NucleoSpin RNA purification kit (Macherey-Nagel), treated with DNAse and stored at -80°C. Five completely independent replicates were prepared in parallel and three were chosen for further sequencing. Messenger RNA samples were indexed and sequenced using the Illumina HiSeq 2000 technology to obtain paired-end 100 bp-long reads with a coverage of 20 million reads per sample.

The bioinformatics analyses were as followed: reads were aligned to the C. elegans genome form Wormbase version WS235 (www.wormbase.org) by Tophat2 [84] (ccb.jhu.edu/software/tophat/index.shtml), followed by differential expression analysis using Cuffdiff [84] (cole-trapnell-lab.github.io/cufflinks/cuffdiff/) and ABSSeq [85]. K-means clustering analysis was done using Cluster 3.0 [86] (bonsai.hgc.jp/~mdehoon/software/cluster/software.htm) with a k of 10 for both experiments. A heatmap was created using TreeView version 1.1.4r3 [87]. Promoter region motif enrichment analysis was done on the promoter regions -600 bp and 250 bp relative to transcription start sites of the genes in each cluster with the software AMD [88]. Enrichment analysis of each cluster or groups of up- and downregulated genes was done using EASE [89], DAVID [90,91] and WormExp [92] (wormexp.zoologie.uni-kiel.de/wormexp/).

For the second transcriptomic study all procedures and analyses were as in the first transcriptomic study except that control and elt-2 knockdown worms treated with RNAi bacteria for 48 h starting at the L1 larval stage were exposed to different concentrations of pathogenic Bt247 and Bt679. Since the first transcriptomic study established that there were no significant differences in expression between E. coli OP50 and the non-pathogenic Bt407, a single concentration of Bt407 equivalent to the highest used for pathogenic Bt strains was used. Samples were collected 6 h and 12 h p.i, since these were the time points with the most significant strain-specific expression changes in the first transcriptomic study. Survival rate after 24 h p.i. was assessed for all treatments and those with 70% survival on pathogenic Bt strains were chosen for sequencing. As in the first transcriptomic study five completely independent replicates were prepared in parallel and three were chosen for further sequencing. Bioinformatic analyses were as in the first transcriptomic study.

Bacterial load assessment by counting colony forming units (CFUs)

Bacterial load was estimated by exposing the worms as described for the survival assays and at 12 h p.i. five worms were picked to 50 μL M9 buffer supplemented with 25 mM tetramisole (TM buffer) and washed two times with TM buffer supplemented with 100 μL/mL gentamicin and two additional times with M9 buffer. After washing, worms were resuspended in 150 μL PBS supplemented with 1% Triton X-100, zirconia beads (1 mm in diameter) were added, and worms were ground using a SPEX SamplePrep 2000 GenoGrinder Tissue Homogenizer at 1200 strokes/min for 3 minutes. The worm lysate was serially diluted in PBS and the dilutions 1:100 and 1:1000 were plated on LB agar in triplicate and incubated at 20°C for 48 h for colony counting. The buffer from the last wash was also plated in triplicate to assess washing efficiency. Five worms from each treatment were mounted onto microscope slides and their length was measured using a Leica M165 FC Fluorescence Stereomicroscope and the LAS software. Worm length was used to normalize the bacterial load per mm of worm as elt-2(RNAi) and empty vector worms have different lengths.

Fluorescence, light microscopy and transmission electron microscopy (TEM)

For fluorescence microscopy elt-2(RNAi) worms were exposed to Bt in 6 cm diameter plates and at each time point 10 worms were transferred to a microscopic slide with an agar pad, immobilized with 50 mM sodium azide and observed with a Carl Zeiss Observer Z.1 inverted fluorescence microscope or the confocal Carl Zeiss LSM 700. For light microscopy, samples were observed under the Carl Zeiss Observer Z.1 microscope. For TEM, worms were exposed to Bt as described for RNA extractions and washed off plates 12 h p.i. directly with fixation solution (2.5% glutaraldehyde, 2% paraformaldehyde, 0,1 M cacodylate buffer pH 7.2). Worms were cut in half to ensure penetration of the fixation solution and prepared as described in [93] for visualization with a Tecnai 2 electron microscope in the microscopy facility of the Biology Tower at the Christian-Albrechts University Kiel.

Western blot

1000 worms were prepared on 9 cm NGM plates and exposed to bacteria as described for survival experiments. 6 h p.i. worms were washed with M9 buffer and protein extraction was done using standard methods [94]. Briefly, around 150 to 3000 worms were collected in 2 mL safe-lock Eppendorf tubes and centrifuged at 500 rpm for 1 min. Supernatant was discarded and samples were resuspended in lysis buffer (for 500 μL lysis buffer use: 5 μL proteinase supplemented with phosphatase inhibitor (ThermoFisher), 5 μL glycerol, 50 μL sodium deoxycholate (10%), 1.1 μL ethylenediaminetetraacetic acid (EDTA) (0.45M), 438,9 μL buffer (for 500 mL buffer use: 3.0 g Tris pH 8, 4.4 g NaCl, 5 mL Triton X-100, complete to volume with deionized water)). Samples were cycled seven times between freezing in liquid nitrogen and thawing at 37°C with vortexing in between. After cycling, samples were incubated on ice for 10 min and then centrifuged at 13,000 rpm for 10 min at 4°C. Supernatant was pipetted to a new 1.5 mL Eppendorf tube and stored at -20°C for later use. Protein samples were probed with anti-ELT-2 monoclonal antibody provided by James McGhee, University of Calgary, AB, Canada, and anti-actin clone C4 monoclonal antibody (Millipore, Cat. # MAB1501R, Lot # 2387816), followed by goat anti-mouse-IgG (H+L) HRP conjugate (Advansta, Part number: R-05071-500, Lot number: 110922–26). PageRuler Plus prestained ladder (Thermo Fischer, Product # 26619, Lot # 00119113) was used. Samples were visualized using SuperSignal West Pico Chemiluminescent substrate (Thermo Scientific, product #34080).

Intestinal integrity assay (Smurf)

The smurf worm protocol was followed as previously described [95]. Briefly, worms were infected as described in the Bt survival assay section and after 24 h p.i. they were washed with 5 mL S buffer (NaCl (100 mM), K2HPO4 (6.5 mM), and KH2PO4 (43.5 mM)), spun down and resuspended in an overnight liquid E. coli OP50 culture mixed with blue food dye (Erioglaucine disodium salt, Sigma-Aldrich; 0.05g/mL) for three hours. Animals were then washed three times with S buffer, centrifuged at 3500 rpm for 1 min, and 20 μL of the pellet was mounted on microscopic slides with 2% Agarose pads. 10 μL Sodium azide (20 mM) was added to paralyze the worms for imaging and scoring 30 worms for leaking and non-leaking phenotypes as shown in S2Q and S2R Fig. Samples were visualized using a Zeiss Observer Z.1 microscope and a Leica M165 FC Fluorescence Stereomicroscope.

Crystal production & purification

The three different Bt strains Bt679, Bt247 and Bt247(-Cry6Ba) were grown on LB-agar plates. For each strain, one colony was picked to inoculate an overnight 5 mL LB liquid preculture. Precultures were spread on T3 sporulation medium (per liter: 3g tryptone, 2 g tryptose, 1.5 g yeast extract, 0.05 M phosphate buffer pH 6.8, and 0.005 g of MnCl2) and incubated at 30°C for 4 days to promote Bt sporulation and toxin crystal production. Spores and crystals were collected using a cell scraper, resuspended in water and centrifuged once at 9500 rpm for 45 min. The pellet was resuspended in water. For each strain, an aliquot of unpurified crystals was kept at 4°C for controlling the presence of toxins and as a quality control of the purification step. Crystals from Bt679 and Bt247 strains were purified using a discontinuous sucrose gradient (67-72-79%) using a SW-32 Ti swinging-bucket rotor on an Optima XPN ultracentrifuge (Beckman Coulter). After 16 h of ultracentrifugation at 23,000 g and 4°C, the crystals were recovered from the 67–72% interphase for Bt247 and from both the 67–72% and 72–79% interphases for Bt679. Spores, which formed a tight pellet at the bottom of the tubes, were discarded. Crystals were then washed by performing several rounds of centrifugation and resuspension in water to discard as much sucrose as possible. Purified crystals were stored in water at 4°C until use.

Quality control of crystal productions

Quality control of crystal products was done as described in [96]. Briefly, unpurified productions and purified crystals suspensions were verified on SDS-PAGE 12% gels. Laemmli buffer containing 10 mM dithiothreitol (DTT) was added to the samples, which were then heated at 95°C for 5 min prior to loading on the gel. Migration was performed at 110V for 2 h and gels were stained overnight using InstantBlue Coomassie straining (Sigma Aldrich). The gels were subsequently washed several times with water and digitalized using a ChemiDoc XRS+ and ImageLab software version 6.0.0 (Bio-Rad). Intensity of the peaks corresponding to the different Bt679 toxins were analyzed with ImageJ software v1.51k [97]. Purified Bt247 crystals were additionally analyzed by MALDI-ToF mass spectrometry using an Autoflex mass spectrometer (Bruker Daltonics, Bremen, Germany) operated in linear positive ion mode. External mass calibration of the instrument, for the 10–70 kDa m/z range, was carried out using protein calibration standard II from Bruker Daltonics. Bt247 crystals were dissolved in an acetonitrile (ACN)-water mixture (70:30, v/v) and then mixed at different ratios with a sinapinic acid (SA) matrix (Sigma; 20 mg mL-1 in water/ACN/trifluoroacetic acid, 70:30:0.1, v:v:v) to obtain the best signal-to-noise spectra. Considering that all ratios gave similar results, only the 1:5 (v:v) ratio is shown. 1–2 μL of the mixture were deposited on the target and allowed to air dry. Mass spectra were acquired in the 10 to 160 kDa m/z range and data processed with Flexanalysis software (v.3.0, Bruker Daltonics).

Generation of transgenic C. elegans strains

The transcriptional reporter nhr-193p::GFP contains 658 bp of genomic region upstream of the nhr-193 start codon. It was generated by fusion PCR [98] using the primers SHP860, SHP861 and SHP862 (S7 Table), and injected into unc-119(ed3) animals at a concentration of 10 ng/μl together with the co-injection marker myo-2p::RFP at a concentration of 25 ng/μl, and the unc-119 rescue construct pPK605 (Addgene) at 20 ng/μl, yielding one transgenic line, MY1094 [unc-119(ed3); yaEx80[pnhr-193::GFP; myo-2p::RFP; pPK605]], which was analyzed here. pPK605 was a gift from Patricia Kuwabara (Addgene plasmid # 38148; http://n2t.net/addgene:38148; RRID:Addgene_38148).

All phenotypic raw data used to produce the figures in the main text and supplemental material can be found in S8 Table. The results of the statistical tests performed on the phenotypic raw data, as indicated in the figure legends, can be found in S9 Table.

Supporting information

S1 Fig. The opposite elt-2(RNAi) survival phenotype is not due to differences in Bt strain virulence and is not affected by the intestinal GATA TF elt-7.

Related to Fig 3. (A) Survival of elt-2(RNAi) (dashed lines) and RNAi control worms (solid lines) 24 h p.i. with Bt247 and Bt679. The figure represents the same data that are shown in Fig 3C and 3D and in run I of Fig 3E but here they are plotted in the same coordinate axes. In this way it is visible that Bt679 is able to kill the host to the same extent as Bt247 but at lower concentration, showing that Bt679 is more virulent than Bt247. (B) Survival of elt-2(RNAi) and RNAi control worms 24 h p.i. with different cultures of Bt247 and Bt679 compared to (A). Both Bt strains kill the same proportion of hosts at the same concentration, showing that they have the same level of virulence. The opposite survival phenotype is also observed in elt-2(RNAi) worms when they are exposed to Bt247 and Bt679 with the same virulence levels. Mean and SEM are shown, N = 5 plates with 30 worms each. Statistics as in Fig 3E. *** shows p-value < 0.001 comparing RNAi to controls. Bonferroni adjusted. (C) elt-7 knockout mutants do not exhibit a Bt strain-specific survival phenotype. Heat maps show difference in survival at 24 h p.i. between wildtype N2 and elt-7(tm840) and elt-7(ok835) mutant animals. As in Fig 3, the shadowing between survival curves of elt-2(RNAi) and controls in (A-B) reflects higher or lower survival of treatment compared to control as indicated in the color scale bar of (C).

(TIF)

S2 Fig. elt-2(RNAi) worms maintain integrity of the intestinal epithelium during Bt247 infection.

Related to Fig 4. (A-P) Fluorescence images and fluorescence merged with bright field images of the strain BJ49 carrying an IFB-2::CFP transgene 24 h after exposure to (A-D) E. coli OP50 (E-H), Bt407 (I-L) Bt247, and (M-P) Bt679. Scale bars represent 100 μm. IFB-2 is a structural component of the intestinal terminal web [99]. The CFP tag surrounds the intestinal lumen and is seen as two parallel thin continuous lines when healthy worms are inspected under the fluorescence microscope [99]. Damage in the intestinal epithelium can be observed when these continuous thin lines produce gaps, twists, blur or collapse into one line [100]. Consistent with the results of the TEM analysis (Fig 4C–4N), we found that low survival rate of elt-2(RNAi) worms after Bt679 infection coincides with exacerbated damage to the intestinal brush border and terminal web (S2O and S2P Fig) compared to empty vector controls (S2M and S2N Fig). However, higher tolerance of elt-2(RNAi) to Bt247 (S2I and S2J Fig) infection coincides with substantially less damage at the intestinal epithelium compared to control worms (S2K and S2L Fig). Worms exposed to non-pathogenic bacteria show no damage to their intestinal brush border and terminal web at 2 h p.i., regardless of the elt-2(RNAi) treatment (S2A–S2H Fig). (Q-S) Smurf assay to assess intestinal epithelium integrity [95]. At 24 h p.i. worms were exposed for 3 hours to E. coli OP50 with blue food dye. We observed if there was leaking of the dye from the intestinal lumen into the intestinal cells as a proxy for disruption of intestinal integrity. We show a representative picture of (Q) a non-leaking intestine (integral), (R) a leaking intestine (loss of integrity or damage), respectively indicated by arrows, and (S) the relative frequency of intestinal damage of worms exposed to Bt679, Bt247 and bacterial controls. Damage was scored as a binary observation (present/absent) of blue food dye leaking inside intestinal cells as opposed to remaining contained in the intestinal lumen. 30 worms per treatment were observed and the relative frequency was calculated as the number of worms presenting damage over the total number of worms per treatment. Mean and SEM are shown N = 3, Mann Whitney U test Bonferroni adjusted, *** indicates p < 0.001. We found that elt-2(RNAi) worms infected with Bt679 showed no difference, whereas those infected with Bt247 showed significantly lower damage than the empty vector controls (S2S Fig).

(TIF)

S3 Fig. Subset of the survival curves used to construct the heatmaps in Fig 5A.

Related to Fig 5. (A and B) Survival of wildtype N2, pmk-1(km25) mutant, elt-2(RNAi), and pmk-1(km25);elt-2(RNAi) animals 24 h p.i. with (A) Bt679 and (B) Bt247. In A and B dashed lines represent worms with elt-2(RNAi) treatment. Mean and SEM are shown, N = 5 plates with 30 worms each. The figure represents the same data that are shown in Fig 5A run I. Statistics as in Fig 3E. *** shows p-value < 0.001 comparing RNAi to empty vector, +++ shows p-value < 0.001 comparing mutant to N2. Bonferroni adjusted. Green dots in (A-B) represent survival of worms exposed to Bt407. Our results suggest that the p38 MAPK pathway is required for the C. elegans defense to Bt679, but dispensable for the defense response to Bt247.

(TIF)

S4 Fig. Variation in elt-2 mediated effects upon exposure to different Bt toxins.

Related to Fig 5. SDS-PAGE gel (12% of samples loaded with Laemmli buffer and DTT, heated five minutes at 95°C, run at 110V for 2 h, and stained with InstantBlue overnight) showing (A) purified crystal bands from a culture of Bt679, including the nematicidal Cry toxins Cry14Aa and Cry21Aa, and (B) purified Bt247 toxin, showing one unique purified crystal band between 40 and 50 kDa (expected from sequence: 44 kDa) corresponding to Cry6Ba (not present in Bt247 -Cry6Ba). (C) MALDI analysis of the Bt247 toxin, with 34 μM (1,5mg/mL) of sample re-suspended in 100 μI water (70:30) and matrix SA dd (200 mg/mL; I/H20/TFA 70:30:0,1), confirms that the major crystal produced is a monomer of 44 kDa (expected for Cry6Ba). There are also different charges for the same toxin (bicharged = 44 kDa/ 2 charges = 22). Similarly, a small amount of dimer is detected (91 kDa). (D) elt-2(RNAi) worms are more susceptible to infection with the BT strains Bt243, Bt245, and Bt246. Difference in survival between N2 control and elt-2(RNAi) animals 24 h p.i. with additional nematicidal strains Bt243, Bt245 and Bt246. (E) Survival of N2 wildtype control animals 24 h p.i. with either wildtype Bt247, expressing the Cry6Ba toxin, or Bt247(-Cry6Ba), which lacks the toxin genes and was thus unable to kill C. elegans. (F) Boxplots show survival of N2 wildtype control animals 48 h p.i. with purified Cry6Ba toxin resuspended in PBS or in spore solutions of the indicated Bt strains. Purified Cry6Ba diluted with PBS or mixed together with Bt spores at a range of concentrations between 1:2 to 1:1000000 was not able to kill worms. (G) difference in survival between N2 wildtype controls and elt-2(RNAi) animals 24 h after exposure to different dilutions of a mix of crystal toxins purified from a culture of Bt679. (H) elt-2 is required for survival after exposure to the Bt679 PFT Cry21Aa3 but not Cry14Aa2. elt-2(RNAi) worms exposed to Bt679(-Cry) expressing either Cry14Aa2 (Cry14A), Cry21Aa3 (Cry21A) or RFP. Evolved Bt247 and Bt679 strains that have lost their Cry toxin genes are unable to kill nematode hosts, confirming that Bt247 and Bt679 Cry toxins are essential virulence factors (S3E and S3H Fig (RFP, green dots)). In E, G and H mean and SEM are shown, N = 4 (except for H, where N = 3) plates with 30 worms each. Statistics as in Fig 3. *** shows p-value < 0.001 comparing RNAi to wildtype N2 or empty vector controls. Bonferroni adjusted. Green dots in (E) represent survival of worms exposed to Bt407 and in (H) survival of worms exposed to Bt679(-Cry)+RFP. In D, G and H data represented in heatmap and statistics as in Fig 3E. We conclude that the level of specificity in the nematode’s response to Bt is not only determined by the pathogen strain, but at least to some extent by individual virulence factors.

(TIF)

S5 Fig. Sterility does not show pathogen strain-specific effects.

Related to Fig 6. In (A, B) we show the difference in survival between the N2 control and (A) the sperm-deficient and sterile RNA-dependent RNA polymerase rrf-3(b26) mutant; (B) the LIN-12/Notch family of receptors member glp-1(ar202) and glp-1(bn18) sterile mutants. Triangles indicate significant difference compared to elt-2(RNAi). Sterile mutants had higher survival than controls both on Bt247 and Bt679, suggesting that the effect of sterility in our infections is not Bt strain specific. Knockdown of elt-2 in the rrf-3(b26), glp-1(ar202), and glp-1(bn18) mutant backgrounds further enhanced the increased survival rate observed in sterile mutants infected with Bt247 and produced higher survival rate on Bt679 than that of elt-2(RNAi) worms alone. Our results suggest that the increased survival rate of sterile mutants on Bt247 and Bt679 is independent of the effect of elt-2. The data represented in the heatmap and statistics as in Fig 3E. In (A-B) worms were grown on RNAi E. coli HT115 plates.

(TIF)

S6 Fig. Nuclear hormone receptor-encoding gene nhr-8 contributes to general responses to Bt. Related to Fig 7.

Difference in survival between the N2 control and the nuclear hormone receptor mutants nhr-8(ok186). A GLM of the binomial family was fitted followed by a Tukey HSD Test (see methods section), where mutant or knockdown worm strains were compared to control strains. Asterisks show significant differences between knockout/knockdown treatment and wildtype N2 control. p-value Bonferroni adjusted. Data represented in heatmap and statistics as in Fig 3E. Triangles indicate significant difference compared to elt-2(RNAi).

(TIF)

S1 Table. Differential gene expression analysis of C. elegans N2 infected with B. thuringiensis Bt247 and Bt679.

(XLSX)

S2 Table. Results of functional enrichment analysis using DAVID per differential gene expression cluster of C. elegans N2 infected with B. thuringiensis Bt247 and Bt679.

(XLSX)

S3 Table. Results of functional enrichment analysis using WormExp per differential gene expression cluster of C. elegans N2 infected with B. thuringiensis Bt247 and Bt679.

(XLSX)

S4 Table. Differential gene expression analysis of C. elegans N2 elt-2(RNAi) worms infected with B. thuringiensis Bt247 and Bt679.

(XLSX)

S5 Table. Results of functional enrichment analysis using DAVID per differential gene expression cluster of C. elegans N2 elt-2(RNAi) worms infected with B. thuringiensis Bt247 and Bt679.

(XLSX)

S6 Table. List of worm and bacterial strains used in this study.

(XLSX)

S7 Table. List of oligonucleotides used in this study.

(XLSX)

S8 Table. Raw phenotypic data.

(XLSX)

S9 Table. Results of statistical tests performed on phenotypic datasets.

(XLSX)

Acknowledgments

We thank Camilo Barbosa, Sabrina Butze, Li Fan, Anke Kloock, Patrick Martin, Luis Ospina, Andrei Papkou, Lena Peters, Carola Petersen, Nadja Schmitz, and the Schulenburg group for support and advice. We thank Michael Shapira and Jonathan Ewbank for valuable comments on the manuscript. We also thank James McGhee for providing the anti-ELT-2 monoclonal antibody, Michael Hengartner for the BJ49 strain, Matthias Leippe for the VC3152 strain, Christina Nielsen-LeRoux for Bt407, and Luca Signor for the MALDI-ToF analysis using the platforms of the Grenoble Instruct-ERIC Center (ISBG: UMS 3518 CNRS-CEA-UGA-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). Knockout strains were provided either by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), or the National Bioresource Project coordinated by S. Mitani.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This project was funded by the German Science Foundation https://www.dfg.de/ (DFG grant DI 1687/2-1 to KD and DFG grant SCHU 1415/15-1 to HS) and benefited from support by the Agence Nationale de la Recherche https://anr.fr/ (grants ANR-17-CE11-0018-01 and ANR-2018-CE11-0005-02 to J.-P.C.). AZ and WY were also funded by the IMPRS for Evolutionary Biology, Germany; HS by a Max-Planck Fellowship, HS and KD by institutional funds from Kiel University; PR and HS, and KD additionally by the DFG under Germany’s Excellence Strategy – EXC 22167-390884018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science. 1999. May 21;284(5418):1313–8. 10.1126/science.284.5418.1313 [DOI] [PubMed] [Google Scholar]
  • 2.Ferrandon D. The complementary facets of epithelial host defenses in the genetic model organism Drosophila melanogaster: from resistance to resilience. Current Opinion in Immunology. 2013. February;25(1):59–70. 10.1016/j.coi.2012.11.008 [DOI] [PubMed] [Google Scholar]
  • 3.Ewbank JJ, Pujol N. Local and long-range activation of innate immunity by infection and damage in C. elegans. Current Opinion in Immunology. 2016. February;38:1–7. 10.1016/j.coi.2015.09.005 [DOI] [PubMed] [Google Scholar]
  • 4.Kurtz J, Franz K. Innate defence: evidence for memory in invertebrate immunity. Nature. 2003. September 4;425(6953):37–8. 10.1038/425037a [DOI] [PubMed] [Google Scholar]
  • 5.Little TJ, Watt K, Ebert D. Parasite-host specificity: experimental studies on the basis of parasite adaptation. Evolution. 2006. January;60(1):31–8. [PubMed] [Google Scholar]
  • 6.Schulenburg H, Ewbank JJ. Diversity and specificity in the interaction between Caenorhabditis elegans and the pathogen Serratia marcescens. BMC Evolutionary Biology. 2004. November 22;4:49 10.1186/1471-2148-4-49 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Schulenburg H, Müller S. Natural variation in the response of Caenorhabditis elegans towards Bacillus thuringiensis. Parasitology. 2004. April;128(4):433–43. [DOI] [PubMed] [Google Scholar]
  • 8.Futo M, Sell MP, Kutzer MAM, Kurtz J. Specificity of oral immune priming in the red flour beetle Tribolium castaneum. Biology Letters. 2017. December 31;13(12):20170632 10.1098/rsbl.2017.0632 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pinaud S, Portet A, Allienne J-F, Belmudes L, Saint-Beat C, Arancibia N, et al. Molecular characterisation of immunological memory following homologous or heterologous challenges in the schistosomiasis vector snail, Biomphalaria glabrata. Developmental & Comparative Immunology. 2019. March 1;92:238–52. [DOI] [PubMed] [Google Scholar]
  • 10.Brehélin Michel, Roch Philippe. Specificity, learning and memory in the innate immune response. ISJ. 2008. July 29;5(2):103–9. [Google Scholar]
  • 11.Bailey M, Christoforidou Z, Lewis M. Evolution of immune systems: Specificity and autoreactivity. Autoimmunity Reviews. 2013. April;12(6):643–7. 10.1016/j.autrev.2012.10.007 [DOI] [PubMed] [Google Scholar]
  • 12.Barribeau SM, Sadd BM, du Plessis L, Schmid-Hempel P. Gene expression differences underlying genotype-by-genotype specificity in a host–parasite system. Proc Natl Acad Sci U S A. 2014. March 4;111(9):3496–501. 10.1073/pnas.1318628111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Leitão AB, Bian X, Day JP, Pitton S, Demir E, Jiggins FM. Independent effects on cellular and humoral immune responses underlie genotype-by-genotype interactions between Drosophila and parasitoids. PLoS Pathogens. 2019. October 7;15(10):e1008084 10.1371/journal.ppat.1008084 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wong D, Bazopoulou D, Pujol N, Tavernarakis N, Ewbank JJ. Genome-wide investigation reveals pathogen-specific and shared signatures in the response of Caenorhabditis elegans to infection. Genome Biology. 2007. September 17;8(9):R194 10.1186/gb-2007-8-9-r194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Irazoqui JE, Troemel ER, Feinbaum RL, Luhachack LG, Cezairliyan BO, Ausubel FM. Distinct Pathogenesis and Host Responses during Infection of C. elegans by P. aeruginosa and S. aureus. PLoS Pathogens. 2010. July 1;6(7):e1000982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Engelmann I, Griffon A, Tichit L, Montañana-Sanchis F, Wang G, Reinke V, et al. A Comprehensive Analysis of Gene Expression Changes Provoked by Bacterial and Fungal Infection in C. elegans. PLoS ONE. 2011. May 13;6(5):e19055 10.1371/journal.pone.0019055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yang W, Dierking K, Rosenstiel PC, Schulenburg H. GATA transcription factor as a likely key regulator of the Caenorhabditis elegans innate immune response against gut pathogens. Zoology. 2016. August 1;119(4):244–53. 10.1016/j.zool.2016.05.013 [DOI] [PubMed] [Google Scholar]
  • 18.Nakad R, Snoek LB, Yang W, Ellendt S, Schneider F, Mohr TG, et al. Contrasting invertebrate immune defense behaviors caused by a single gene, the Caenorhabditis elegans neuropeptide receptor gene npr-1. BMC Genomics. 2016;17:280 10.1186/s12864-016-2603-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yuen GJ, Ausubel FM. Both live and dead Enterococci activate Caenorhabditis elegans host defense via immune and stress pathways. Virulence. 2018. March 19;9(1):683–99. 10.1080/21505594.2018.1438025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Dierking K, Yang W, Schulenburg H. Antimicrobial effectors in the nematode Caenorhabditis elegans: an outgroup to the Arthropoda. Phil Trans R Soc B. 2016. May 26;371(1695):20150299 10.1098/rstb.2015.0299 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Pees B, Yang W, Zárate-Potes A, Schulenburg H, Dierking K. High Innate Immune Specificity through Diversified C-Type Lectin-Like Domain Proteins in Invertebrates. JIN. 2016;8(2):129–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Borgonie G, Van Driessche R, Leyns F, Arnaut G, De Waele D, Coomans A. Germination of Bacillus thuringiensis Spores in Bacteriophagous Nematodes (Nematoda: Rhabditida). Journal of Invertebrate Pathology. 1995. January 1;65(1):61–7. 10.1006/jipa.1995.1008 [DOI] [PubMed] [Google Scholar]
  • 23.Huffman DL, Abrami L, Sasik R, Corbeil J, van der Goot FG, Aroian RV. Mitogen-activated protein kinase pathways defend against bacterial pore-forming toxins. Proc Natl Acad Sci USA. 2004. July 27;101(30):10995–1000. 10.1073/pnas.0404073101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bischof LJ, Kao C-Y, Los FCO, Gonzalez MR, Shen Z, Briggs SP, et al. Activation of the Unfolded Protein Response Is Required for Defenses against Bacterial Pore-Forming Toxin In Vivo. PLoS Pathogens. 2008. October 10;4(10):e1000176 10.1371/journal.ppat.1000176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bellier A, Chen C-S, Kao C-Y, Cinar HN, Aroian RV. Hypoxia and the Hypoxic Response Pathway Protect against Pore-Forming Toxins in C. elegans. PLOS Pathogens. 2009. December 11;5(12):e1000689 10.1371/journal.ppat.1000689 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chen C-S, Bellier A, Kao C-Y, Yang Y-L, Chen H-D, Los FCO, et al. WWP-1 is a novel modulator of the DAF-2 insulin-like signaling network involved in pore-forming toxin cellular defenses in Caenorhabditis elegans. PLoS ONE. 2010. March 2;5(3):e9494 10.1371/journal.pone.0009494 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kao C-Y, Los FCO, Huffman DL, Wachi S, Kloft N, Husmann M, et al. Global Functional Analyses of Cellular Responses to Pore-Forming Toxins. PLOS Pathogens. 2011. March 3;7(3):e1001314 10.1371/journal.ppat.1001314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Los FCO, Kao C-Y, Smitham J, McDonald KL, Ha C, Peixoto CA, et al. RAB-5- and RAB-11-Dependent Vesicle-Trafficking Pathways Are Required for Plasma Membrane Repair after Attack by Bacterial Pore-Forming Toxin. Cell Host & Microbe. 2011. February 17;9(2):147–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chen H-D, Kao C-Y, Liu B-Y, Huang S-W, Kuo C-J, Ruan J-W, et al. HLH-30/TFEB-mediated autophagy functions in a cell-autonomous manner for epithelium intrinsic cellular defense against bacterial pore-forming toxin in C. elegans. Autophagy. 2016. November 22;13(2):371–85. 10.1080/15548627.2016.1256933 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wang B, Wang H, Xiong J, Zhou Q, Wu H, Xia L, et al. A Proteomic Analysis Provides Novel Insights into the Stress Responses of Caenorhabditis elegans towards Nematicidal Cry6A Toxin from Bacillus thuringiensis. Sci Rep. 2017. October 26;7 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658354/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Papkou A, Guzella T, Yang W, Koepper S, Pees B, Schalkowski R, et al. The genomic basis of Red Queen dynamics during rapid reciprocal host–pathogen coevolution. PNAS. 2019. January 15;116(3):923–8. 10.1073/pnas.1810402116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Masri L, Branca A, Sheppard AE, Papkou A, Laehnemann D, Guenther PS, et al. Host–Pathogen Coevolution: The Selective Advantage of Bacillus thuringiensis Virulence and Its Cry Toxin Genes. PLOS Biology. 2015. April 6;13(6):e1002169 10.1371/journal.pbio.1002169 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hollensteiner J, Poehlein A, Spröer C, Bunk B, Sheppard AE, Rosenstiel P, et al. Complete genome sequence of the nematicidal Bacillus thuringiensis MYBT18247. Journal of Biotechnology. 2017. October 20;260:48–52. 10.1016/j.jbiotec.2017.09.003 [DOI] [PubMed] [Google Scholar]
  • 34.Schulte RD, Makus C, Hasert B, Michiels NK, Schulenburg H. Multiple reciprocal adaptations and rapid genetic change upon experimental coevolution of an animal host and its microbial parasite. PNAS. 2010. April 20;107(16):7359–64. 10.1073/pnas.1003113107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wang J, Nakad R, Schulenburg H. Activation of the Caenorhabditis elegans FOXO family transcription factor DAF-16 by pathogenic Bacillus thuringiensis. Developmental & Comparative Immunology. 2012. May 1;37(1):193–201. [DOI] [PubMed] [Google Scholar]
  • 36.Sheppard AE, Poehlein A, Rosenstiel P, Liesegang H, Schulenburg H. Complete Genome Sequence of Bacillus thuringiensis Strain 407 Cry-. Genome Announc. 2013. February 28;1(1):e00158–12. 10.1128/genomeA.00158-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Hall David H., Altun Zeynep F. C. elegans Atlas. Cold Spring Harbor Laboratory Press; 2008. Available from: http://www.wormatlas.org [Google Scholar]
  • 38.Boehnisch C, Wong D, Habig M, Isermann K, Michiels NK, Roeder T, et al. Protist-Type Lysozymes of the Nematode Caenorhabditis elegans Contribute to Resistance against Pathogenic Bacillus thuringiensis. PLoS ONE. 2011. September 8;6(9):e24619 10.1371/journal.pone.0024619 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zhang F, Peng D, Cheng C, Zhou W, Ju S, Wan D, et al. Bacillus thuringiensis Crystal Protein Cry6Aa Triggers Caenorhabditis elegans Necrosis Pathway Mediated by Aspartic Protease (ASP-1). PLOS Pathogens. 2016. January 21;12(1):e1005389 10.1371/journal.ppat.1005389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Shapira M, Hamlin BJ, Rong J, Chen K, Ronen M, Tan M-W. A conserved role for a GATA transcription factor in regulating epithelial innate immune responses. Proc Natl Acad Sci U S A. 2006. September 19;103(38):14086–91. 10.1073/pnas.0603424103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Block DH, Shapira M. GATA transcription factors as tissue-specific master regulators for induced responses. Worm. 2015. December;4(4):e1118607 10.1080/21624054.2015.1118607 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kerry S, TeKippe M, Gaddis NC, Aballay A. GATA Transcription Factor Required for Immunity to Bacterial and Fungal Pathogens. PLoS ONE. 2006. December 20;1(1):e77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.McGhee JD, Sleumer MC, Bilenky M, Wong K, McKay SJ, Goszczynski B, et al. The ELT-2 GATA-factor and the global regulation of transcription in the C. elegans intestine. Developmental Biology. 2007. February 15;302(2):627–45. 10.1016/j.ydbio.2006.10.024 [DOI] [PubMed] [Google Scholar]
  • 44.Wiesenfahrt T, Berg JY, Nishimura EO, Robinson AG, Goszczynski B, Lieb JD, et al. The function and regulation of the GATA factor ELT-2 in the C. elegans endoderm. Development. 2016. February 1;143(3):483–91. 10.1242/dev.130914 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sommermann EM, Strohmaier KR, Maduro MF, Rothman JH. Endoderm development in C. elegans: the synergistic action of ELT-2 and -7 mediates the specification→differentiation transition. Dev Biol. 2010. November 1;347(1):154–66. 10.1016/j.ydbio.2010.08.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Dineen A, Nishimura EO, Goszczynski B, Rothman JH, McGhee JD. Quantitating transcription factor redundancy: The relative roles of the ELT-2 and ELT-7 GATA factors in the C. elegans endoderm. Dev Biol. 2018. March 15;435(2):150–61. 10.1016/j.ydbio.2017.12.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Block DHS, Twumasi-Boateng K, Kang HS, Carlisle JA, Hanganu A, Lai TY-J, et al. The Developmental Intestinal Regulator ELT-2 Controls p38-Dependent Immune Responses in Adult C. elegans. PLoS Genet. 2015. May 27;11(5):e1005265 10.1371/journal.pgen.1005265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.McGhee JD, Fukushige T, Krause MW, Minnema SE, Goszczynski B, Gaudet J, et al. ELT-2 Is the Predominant Transcription Factor Controlling Differentiation and Function of the C. elegans Intestine, from Embryo to Adult. Dev Biol. 2009. March 15;327(2):551–65. 10.1016/j.ydbio.2008.11.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Lee S-H, Wong R-R, Chin C-Y, Lim T-Y, Eng S-A, Kong C, et al. Burkholderia pseudomallei suppresses Caenorhabditis elegans immunity by specific degradation of a GATA transcription factor. Proc Natl Acad Sci U S A. 2013. September 10;110(37):15067–72. 10.1073/pnas.1311725110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Ferrandon D. Host tolerance versus resistance and microbial virulence in the host-pathogen equation. Cell Host Microbe. 2009. September 17;6(3):203–5. 10.1016/j.chom.2009.08.010 [DOI] [PubMed] [Google Scholar]
  • 51.Medzhitov R, Schneider DS, Soares MP. Disease Tolerance as a Defense Strategy. Science. 2012. February 24;335(6071):936–41. 10.1126/science.1214935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Råberg L, Graham AL, Read AF. Decomposing health: tolerance and resistance to parasites in animals. Philos Trans R Soc Lond B Biol Sci. 2009. January 12;364(1513):37–49. 10.1098/rstb.2008.0184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Tetreau G. Interaction between Insects, Toxins, and Bacteria: Have We Been Wrong So Far? Toxins. 2018. July;10(7):281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Råberg L, Sim D, Read AF. Disentangling Genetic Variation for Resistance and Tolerance to Infectious Diseases in Animals. Science. 2007. November 2;318(5851):812–4. 10.1126/science.1148526 [DOI] [PubMed] [Google Scholar]
  • 55.Restif O, Koella JC. Concurrent Evolution of Resistance and Tolerance to Pathogens. The American Naturalist. 2004. October 1;164(4):E90–102. 10.1086/423713 [DOI] [PubMed] [Google Scholar]
  • 56.Ayres JS, Schneider DS. A Signaling Protease Required for Melanization in Drosophila Affects Resistance and Tolerance of Infections. PLOS Biology. 2008. September 12;6(12):e305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, Inoue H, et al. A Conserved p38 MAP Kinase Pathway in Caenorhabditis elegans Innate Immunity. Science. 2002. July 26;297(5581):623–6. 10.1126/science.1073759 [DOI] [PubMed] [Google Scholar]
  • 58.Head BP, Olaitan AO, Aballay A. Role of GATA transcription factor ELT-2 and p38 MAPK PMK-1 in recovery from acute P. aeruginosa infection in C. elegans. Virulence. 2016. August 11;0(0):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Sharma A, Kumar S, Bhatnagar RK. Bacillus thuringiensis Protein Cry6B (BGSC ID 4D8) is Toxic to Larvae of Hypera postica. Curr Microbiol. 2011. February 1;62(2):597–605. 10.1007/s00284-010-9749-4 [DOI] [PubMed] [Google Scholar]
  • 60.Wei J-Z, Hale K, Carta L, Platzer E, Wong C, Fang S-C, et al. Bacillus thuringiensis crystal proteins that target nematodes. PNAS. 2003. March 4;100(5):2760–5. 10.1073/pnas.0538072100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Pirie CM, Liu DV, Wittrup KD. Targeted Cytolysins Synergistically Potentiate Cytoplasmic Delivery of Gelonin Immunotoxin. Mol Cancer Ther. 2013. July 5; Available from: https://mct.aacrjournals.org/content/early/2013/08/23/1535-7163.MCT-12-1023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Los FCO, Randis TM, Aroian RV, Ratner AJ. Role of Pore-Forming Toxins in Bacterial Infectious Diseases. Microbiol Mol Biol Rev. 2013. June 1;77(2):173–207. 10.1128/MMBR.00052-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Griffitts JS, Haslam SM, Yang T, Garczynski SF, Mulloy B, Morris H, et al. Glycolipids as Receptors for Bacillus thuringiensis Crystal Toxin. Science. 2005. February 11;307(5711):922–5. 10.1126/science.1104444 [DOI] [PubMed] [Google Scholar]
  • 64.Miyata S, Begun J, Troemel ER, Ausubel FM. DAF-16-Dependent Suppression of Immunity During Reproduction in Caenorhabditis elegans. Genetics. 2008. February 1;178(2):903–18. 10.1534/genetics.107.083923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Priess JR, Schnabel H, Schnabel R. The glp-1 locus and cellular interactions in early C. elegans embryos. Cell. 1987. November 20;51(4):601–11. 10.1016/0092-8674(87)90129-2 [DOI] [PubMed] [Google Scholar]
  • 66.Friedman DB, Johnson TE. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics. 1988. January 1;118(1):75–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Griffitts JS, Huffman DL, Whitacre JL, Barrows BD, Marroquin LD, Müller R, et al. Resistance to a Bacterial Toxin Is Mediated by Removal of a Conserved Glycosylation Pathway Required for Toxin-Host Interactions. J Biol Chem. 2003. November 14;278(46):45594–602. 10.1074/jbc.M308142200 [DOI] [PubMed] [Google Scholar]
  • 68.Cohen LB, Troemel ER. Microbial pathogenesis and host defense in the nematode C. elegans. Curr Opin Microbiol. 2015. February;23:94–101. 10.1016/j.mib.2014.11.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Zou C-G, Ma Y-C, Dai L-L, Zhang K-Q. Autophagy protects C. elegans against necrosis during Pseudomonas aeruginosa infection. PNAS. 2014. August 26;111(34):12480–5. 10.1073/pnas.1405032111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Marsh EK, van den Berg MCW, May RC. A Two-Gene Balance Regulates Salmonella Typhimurium Tolerance in the Nematode Caenorhabditis elegans. PLoS One. 2011. March 2;6(3):e0016839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Watts JL, Ristow M. Lipid and Carbohydrate Metabolism in Caenorhabditis elegans. Genetics. 2017;207(2):413–46. 10.1534/genetics.117.300106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Marza E, Simonsen KT, Færgeman NJ, Lesa GM. Expression of ceramide glucosyltransferases, which are essential for glycosphingolipid synthesis, is only required in a small subset of C. elegans cells. J Cell Sci. 2009. March 15;122(6):822–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Goudeau J, Bellemin S, Toselli-Mollereau E, Shamalnasab M, Chen Y, Aguilaniu H. Fatty Acid Desaturation Links Germ Cell Loss to Longevity Through NHR-80/HNF4 in C. elegans. PLOS Biology. 2011. March 15;9(3):e1000599 10.1371/journal.pbio.1000599 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Watts JL. Using Caenorhabditis elegans to Uncover Conserved Functions of Omega-3 and Omega-6 Fatty Acids. J Clin Med. 2016. February 2;5(2). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773775/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Antebi A. Nuclear receptor signal transduction in C. elegans. WormBook. 2015. June 9;1–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Lindblom TH, Pierce GJ, Sluder AE. A C. elegans orphan nuclear receptor contributes to xenobiotic resistance. Current Biology. 2001. June 1;11(11):864–8. 10.1016/s0960-9822(01)00236-6 [DOI] [PubMed] [Google Scholar]
  • 77.Lindblom TH, Dodd AK. Xenobiotic Detoxification in the Nematode Caenorhabditis elegans. J Exp Zool A Comp Exp Biol. 2006. September 1;305(9):720–30. 10.1002/jez.a.324 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, Kim DH. p38 MAPK Regulates Expression of Immune Response Genes and Contributes to Longevity in C. elegans. PLOS Genetics. 2006. October 11;2(11):e183 10.1371/journal.pgen.0020183 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Ziegler K, Kurz CL, Cypowyj S, Couillault C, Pophillat M, Pujol N, et al. Antifungal Innate Immunity in C. elegans: PKCδ Links G Protein Signaling and a Conserved p38 MAPK Cascade. Cell Host & Microbe. 2009. April 23;5(4):341–52. [DOI] [PubMed] [Google Scholar]
  • 80.Stiernagle T. Maintenance of C. elegans. WormBook; 2006. Available from: https://www.ncbi.nlm.nih.gov/books/NBK19649/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Kissoyan KAB, Drechsler M, Stange E-L, Zimmermann J, Kaleta C, Bode HB, et al. Natural C. elegans Microbiota Protects against Infection via Production of a Cyclic Lipopeptide of the Viscosin Group. Current Biology. 2019. March 18;29(6):1030–1037.e5. 10.1016/j.cub.2019.01.050 [DOI] [PubMed] [Google Scholar]
  • 82.R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: the R Foundation for Statistical Computing; 2011; Available from: http://www.R-project.org/ [Google Scholar]
  • 83.Kamath RS, Ahringer J. Genome-wide RNAi screening in Caenorhabditis elegans. Methods. 2003. August;30(4):313–21. 10.1016/s1046-2023(03)00050-1 [DOI] [PubMed] [Google Scholar]
  • 84.Ghosh S, Chan C-KK. Analysis of RNA-Seq Data Using TopHat and Cufflinks. Methods Mol Biol. 2016;1374:339–61. 10.1007/978-1-4939-3167-5_18 [DOI] [PubMed] [Google Scholar]
  • 85.Yang W, Rosenstiel PC, Schulenburg H. ABSSeq: a new RNA-Seq analysis method based on modelling absolute expression differences. BMC Genomics. 2016. 04;17:541 10.1186/s12864-016-2848-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.de Hoon MJL, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics. 2004. June 12;20(9):1453–4. 10.1093/bioinformatics/bth078 [DOI] [PubMed] [Google Scholar]
  • 87.Saldanha AJ. Java Treeview—extensible visualization of microarray data. Bioinformatics. 2004. November 22;20(17):3246–8. 10.1093/bioinformatics/bth349 [DOI] [PubMed] [Google Scholar]
  • 88.Shi J, Yang W, Chen M, Du Y, Zhang J, Wang K. AMD, an Automated Motif Discovery Tool Using Stepwise Refinement of Gapped Consensuses. PLOS ONE. 2011. December 9;6(9):e24576 10.1371/journal.pone.0024576 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biology. 2003. September 11;4(10):R70 10.1186/gb-2003-4-10-r70 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. 10.1038/nprot.2008.211 [DOI] [PubMed] [Google Scholar]
  • 91.Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009. January;37(1):1–13. 10.1093/nar/gkn923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Yang W, Dierking K, Schulenburg H. WormExp: a web-based application for a Caenorhabditis elegans-specific gene expression enrichment analysis. Bioinformatics. 2016. 15;32(6):943–5. 10.1093/bioinformatics/btv667 [DOI] [PubMed] [Google Scholar]
  • 93.Hall DH, Hartwieg E, Nguyen KCQ. Chapter 4—Modern Electron Microscopy Methods for C. elegans. In: Singson JHR and A, editor. Methods in Cell Biology Academic Press; 2012. p. 93–149. (Caenorhabditis elegans: Cell Biology and Physiology; vol. 107). Available from: http://www.sciencedirect.com/science/article/pii/B9780123946201000047 [DOI] [PubMed] [Google Scholar]
  • 94.Chan K, Seetharaman A, Selman G, Roy P. Immunoprecipitation of Proteins in Caenorhabditis elegans. BIO-PROTOCOL. 2015;5(7). Available from: http://www.bio-protocol.org/e1436 [Google Scholar]
  • 95.Gelino S, Chang JT, Kumsta C, She X, Davis A, Nguyen C, et al. Intestinal Autophagy Improves Healthspan and Longevity in C. elegans during Dietary Restriction. PLOS Genetics. 2016. July 14;12(7):e1006135 10.1371/journal.pgen.1006135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Tetreau G, Banneville A-S, Andreeva EA, Brewster AS, Hunter MS, Sierra RG, et al. Serial femtosecond crystallography on in vivo-grown crystals drives elucidation of mosquitocidal Cyt1Aa bioactivation cascade. Nat Commun. 2020. March 2;11(1):1–16. 10.1038/s41467-019-13993-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Girish V, Vijayalakshmi A. Affordable image analysis using NIH Image/ImageJ. Indian J Cancer. 2004. March;41(1):47 [PubMed] [Google Scholar]
  • 98.Hobert O. PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic C. elegans. BioTechniques. 2002. April;32(4):728–30. 10.2144/02324bm01 [DOI] [PubMed] [Google Scholar]
  • 99.Hüsken K, Wiesenfahrt T, Abraham C, Windoffer R, Bossinger O, Leube RE. Maintenance of the intestinal tube in Caenorhabditis elegans: the role of the intermediate filament protein IFC-2. Differentiation. 2008. October 1;76(8):881–s3. 10.1111/j.1432-0436.2008.00264.x [DOI] [PubMed] [Google Scholar]
  • 100.Stutz K, Kaech A, Aebi M, Künzler M, Hengartner MO. Disruption of the C. elegans Intestinal Brush Border by the Fungal Lectin CCL2 Phenocopies Dietary Lectin Toxicity in Mammals. PLOS ONE. 2015. September 6;10(6):e0129381 10.1371/journal.pone.0129381 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Michael R Wessels, James J Collins III

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

27 May 2020

Dear Dr. Dierking,

Thank you very much for submitting your manuscript "A single C. elegans master regulator causes opposite infection outcomes with different strains of the same pathogen species" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.  In particular, it is necessary that you  revise your conclusions to only reflect what can reasonably be concluded based on the data presented.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

James J Collins III

Associate Editor

PLOS Pathogens

Michael Wessels

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: Zárate-Potes, et al. report a significant finding that differential host response to pathogen infection is dramatically influenced by gene expression responses to that infection. This finding is unexpected because as one might predict that loss of a key transcription factor required for normal host response would only render the host compromised for all pathogens. Rather, the authors report that reduction of elt-2 by RNAi renders C. elegans more resistant to one isolate and more sensitive to another. One particularly exciting finding is shown in Figure 4 where there was a change in intestinal integrity in response to different Bt isolates despite equivalent pathogen load. Although the mechanistic basis for this differential outcome remains unclear, the outcome is well documented and will certainly be valuable to the field and spark further studies.

Reviewer #2: This manuscript describes an extensive investigation of the contrasting effects of two Bacillus thuringiensis strains (Bt679 and Bt247) on the nematode Caenorhabditis elegans. Both are able to kill C. elegans, mainly or completely by intestinal damage caused by their different Cry toxins, but the authors show by transcriptome analyses that the responses of the worms have major differences. Exposure of worms to a toxin-negative Bt strain (Bt407) has similar transcriptomic consequences to exposure to standard E. coli food, which is reassuring, but the two toxic Bt strains elicit responses that indicate both shared and distinct consequences to the different strains. The importance of these effects was explored with appropriate mutants or RNAi knockdown. Major pathways implicated in the shared responses include the AP1 factor jun-1; the p38 MAP kinase pathway contributes to resistance to Bt679 but not to Bt247; and the ELT-2 transcription factor has opposite effects in the responses to the two strains.

The most striking result is that RNAi knockdown of the major intestinal transcription factor ELT-2 (a GATA factor) caused increased sensitivity to Bt679, as might be expected, but dramatically increased survival in the presence of Bt247. The authors show that the improved survival is probably due to increased tolerance, as opposed to resistance, because the intestinal damage and pathogen loads are apparently unchanged by elt-2(RNAi).

Much of the manuscript is devoted to attempts, mostly inconclusive, to explain this remarkable effect. The authors write, “increase [of elt-2(RNA worms] in survival on Bt247 is multifactorial, influenced by the nuclear hormone receptors NHR-99 and NHR-193, and also involves lipid metabolism, detoxification, and trehalose catabolism”, but most of this involvement is guesswork and speculation, unfortunately. The putative transcription factors NHR-99 and NHR-193 are shown to have an effect, but their targets are unknown. Analysing the effects of ELT-2 is bound to be hugely complicated since it has transcriptional effects on at least one third of the C. elegans genome (e.g. page 28: 6180 genes are affected by elt-2(RNAi). Moreover, contributions of related/redundant GATA factors such as ELT-7 need to be considered. Sterility effects are not worth reporting in such detail, or including in Figure 8 unless qualified with yet more question marks.

The authors present some excellent EM data, and do a nice job of analyzing the positive contributions of ELT-2 and the p38 MAP kinase pathway to resistance.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: 1. The major concern with this manuscript is the authors’ concluding model that depicts a scenario where elt-2 mediates two distinct responses to different pore-forming toxin inputs. Is it not more likely that intact elt-2 mediates one response program and loss of elt-2 function shows different outcomes depending on the insult? In other words, the different outcome is the result of how loss of elt-2 alters gene expression such that it primes animals beneficially for one toxin and renders animals susceptible to the other. The authors provide some evidence for their conclusion with the nhr versus pmk-1 results but this level of epistasis analysis is not conclusive enough to depict the two responses as entirely distinct as shown in the model. If the authors’ model is correct, it would be incumbent to demonstrate that elt-2 acts not only as a mediator of transcriptional programs in response to pathogens but also as a sensor of the specific pathogen.

2. Perhaps the weakest conclusion of this study is whether necrotic cell death is or is not involved in the pathogenesis. The authors make some contradictory statements about the role of necrosis. In the text, they state they did not find consistent responses on the two Bt isolates with loss of different factors in the necrotic pathway yet in the figure legend title they state that specific responses do not involve the necrosis pathway. I think this issue needs to be clarified. Are there any cellular morphological changes in response to the two distinct Bt isolates indicating similar or different necrotic cell death outcomes?

Reviewer #2: 1. A general criticism of this work is that most of what has been looked at seems to be the consequences of intoxication rather than infection. This is especially true for Bt247, which does not appear to proliferate in the C. elegans intestine. This issue and its implications need to be better addressed.

2. The authors that purified toxins from Bt679 can kill, and showed that Cry21Aa3 rather than Cry14Aa2 is responsible, but purified Cry6Ba from Bt247 had no effect, although deletion of the relevant gene from Bt247 removed toxicity. This is disappointing and needs more explanation or investigation.

3. Most of the experimentation on p.25-28 and in Figure 6 should be greatly shortened or omitted, as much of it is negative, inconclusive or inconsistent (as the authors admit).

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: 1. Figure 1 has a couple of issues that need to be amended. First, the worm image appears to be very similar to WormAtlas and that should be cited if true. Second, the legend needs to be clarified to match what is being shown in A versus B. Third, the authors indicate that microvilli are artificially colored. Anatomically, it appears that the apical membrane is what has been marked throughout. Please clarify these issues in the legend.

2. The title comes across as a bit ostentatious and uninformative. The data seem to show that elt-2 GATA factor regulates a transcriptional response that results in distinct outcomes depending on the pore toxin insult. The title should more adequately reflect those findings.

3. A major conclusion of the authors is that the jun-1 transcription factor regulates the common response to the Bt strains whereas the elt-2 transcription factor mediates the strain-specific response. One could argue that the authors have found two transcriptional response pathways acting in parallel or the elt-2 is a subset of the jun-1. Thus it is unnecessary to distinguish one as regulatory and the other as a mediator given the evidence in hand. “Mediate” could be concluded for both without diminishing the impact of the finding.

Reviewer #2: 4. Page 15 Figure 3G is either unnecessary or wrong.

5. p.22 line -7 ‘after Bt247 infection’ should be presumably be ‘after Bt679 infection’. Also, the Bt247 data in Figure 5A have triangles indicating a stronger effect in elt-2(RNAi); pmk-1 than in elt-2(RNAi) alone, but the heatmaps look identical.

6. p.32 line -6 NHR-93 should be NHR-193.

7. p. 30, 31 and throughout: Transcriptional reporters are preferably written as nhr-193p::GFP, not pnhr-193::GFP

8. p. 41 Zeiss Zeiss

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plospathogens/s/submission-guidelines#loc-materials-and-methods

Decision Letter 1

James J Collins III

21 Jul 2020

Dear Dr. Dierking,

We are pleased to inform you that your manuscript 'The C. elegans GATA transcription factor elt-2 mediates distinct transcriptional responses and opposite infection outcomes towards different Bacillus thuringiensis strains' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

James J Collins III

Section Editor

PLOS Pathogens

Michael Wessels

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: In this substantially revised and improved manuscript, Zarate-Potes, et al. have now clarified their message and strengthened their conclusions. They have worked hard to address all of my concerns including disambiguation of their summary model. Their major conclusion and exciting core finding for this report is the different responses to distinct strains of a bacterial species including a balance (perhaps tradeoff) between tolerance and resistance via different elt-2-dependent gene expression program subsets. Although the molecular mechanisms of sensing and the tradeoff of tolerance and resistance are not yet understood, these remain exciting lines of inquiry for future reports.

Reviewer #2: This is an excellent revision to an interesting and valuable piece of research. The authors' responses to criticisms are thorough and satisfactory, and the manuscript is much improved.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: I have no major issues with this revision.

Reviewer #2: No further issues.

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: (No Response)

Reviewer #2: No further issues.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

James J Collins III

20 Aug 2020

Dear Dr. Dierking,

We are delighted to inform you that your manuscript, "The C. elegans GATA transcription factor elt-2 mediates distinct transcriptional responses and opposite infection outcomes towards different Bacillus thuringiensis strains," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. The opposite elt-2(RNAi) survival phenotype is not due to differences in Bt strain virulence and is not affected by the intestinal GATA TF elt-7.

    Related to Fig 3. (A) Survival of elt-2(RNAi) (dashed lines) and RNAi control worms (solid lines) 24 h p.i. with Bt247 and Bt679. The figure represents the same data that are shown in Fig 3C and 3D and in run I of Fig 3E but here they are plotted in the same coordinate axes. In this way it is visible that Bt679 is able to kill the host to the same extent as Bt247 but at lower concentration, showing that Bt679 is more virulent than Bt247. (B) Survival of elt-2(RNAi) and RNAi control worms 24 h p.i. with different cultures of Bt247 and Bt679 compared to (A). Both Bt strains kill the same proportion of hosts at the same concentration, showing that they have the same level of virulence. The opposite survival phenotype is also observed in elt-2(RNAi) worms when they are exposed to Bt247 and Bt679 with the same virulence levels. Mean and SEM are shown, N = 5 plates with 30 worms each. Statistics as in Fig 3E. *** shows p-value < 0.001 comparing RNAi to controls. Bonferroni adjusted. (C) elt-7 knockout mutants do not exhibit a Bt strain-specific survival phenotype. Heat maps show difference in survival at 24 h p.i. between wildtype N2 and elt-7(tm840) and elt-7(ok835) mutant animals. As in Fig 3, the shadowing between survival curves of elt-2(RNAi) and controls in (A-B) reflects higher or lower survival of treatment compared to control as indicated in the color scale bar of (C).

    (TIF)

    S2 Fig. elt-2(RNAi) worms maintain integrity of the intestinal epithelium during Bt247 infection.

    Related to Fig 4. (A-P) Fluorescence images and fluorescence merged with bright field images of the strain BJ49 carrying an IFB-2::CFP transgene 24 h after exposure to (A-D) E. coli OP50 (E-H), Bt407 (I-L) Bt247, and (M-P) Bt679. Scale bars represent 100 μm. IFB-2 is a structural component of the intestinal terminal web [99]. The CFP tag surrounds the intestinal lumen and is seen as two parallel thin continuous lines when healthy worms are inspected under the fluorescence microscope [99]. Damage in the intestinal epithelium can be observed when these continuous thin lines produce gaps, twists, blur or collapse into one line [100]. Consistent with the results of the TEM analysis (Fig 4C–4N), we found that low survival rate of elt-2(RNAi) worms after Bt679 infection coincides with exacerbated damage to the intestinal brush border and terminal web (S2O and S2P Fig) compared to empty vector controls (S2M and S2N Fig). However, higher tolerance of elt-2(RNAi) to Bt247 (S2I and S2J Fig) infection coincides with substantially less damage at the intestinal epithelium compared to control worms (S2K and S2L Fig). Worms exposed to non-pathogenic bacteria show no damage to their intestinal brush border and terminal web at 2 h p.i., regardless of the elt-2(RNAi) treatment (S2A–S2H Fig). (Q-S) Smurf assay to assess intestinal epithelium integrity [95]. At 24 h p.i. worms were exposed for 3 hours to E. coli OP50 with blue food dye. We observed if there was leaking of the dye from the intestinal lumen into the intestinal cells as a proxy for disruption of intestinal integrity. We show a representative picture of (Q) a non-leaking intestine (integral), (R) a leaking intestine (loss of integrity or damage), respectively indicated by arrows, and (S) the relative frequency of intestinal damage of worms exposed to Bt679, Bt247 and bacterial controls. Damage was scored as a binary observation (present/absent) of blue food dye leaking inside intestinal cells as opposed to remaining contained in the intestinal lumen. 30 worms per treatment were observed and the relative frequency was calculated as the number of worms presenting damage over the total number of worms per treatment. Mean and SEM are shown N = 3, Mann Whitney U test Bonferroni adjusted, *** indicates p < 0.001. We found that elt-2(RNAi) worms infected with Bt679 showed no difference, whereas those infected with Bt247 showed significantly lower damage than the empty vector controls (S2S Fig).

    (TIF)

    S3 Fig. Subset of the survival curves used to construct the heatmaps in Fig 5A.

    Related to Fig 5. (A and B) Survival of wildtype N2, pmk-1(km25) mutant, elt-2(RNAi), and pmk-1(km25);elt-2(RNAi) animals 24 h p.i. with (A) Bt679 and (B) Bt247. In A and B dashed lines represent worms with elt-2(RNAi) treatment. Mean and SEM are shown, N = 5 plates with 30 worms each. The figure represents the same data that are shown in Fig 5A run I. Statistics as in Fig 3E. *** shows p-value < 0.001 comparing RNAi to empty vector, +++ shows p-value < 0.001 comparing mutant to N2. Bonferroni adjusted. Green dots in (A-B) represent survival of worms exposed to Bt407. Our results suggest that the p38 MAPK pathway is required for the C. elegans defense to Bt679, but dispensable for the defense response to Bt247.

    (TIF)

    S4 Fig. Variation in elt-2 mediated effects upon exposure to different Bt toxins.

    Related to Fig 5. SDS-PAGE gel (12% of samples loaded with Laemmli buffer and DTT, heated five minutes at 95°C, run at 110V for 2 h, and stained with InstantBlue overnight) showing (A) purified crystal bands from a culture of Bt679, including the nematicidal Cry toxins Cry14Aa and Cry21Aa, and (B) purified Bt247 toxin, showing one unique purified crystal band between 40 and 50 kDa (expected from sequence: 44 kDa) corresponding to Cry6Ba (not present in Bt247 -Cry6Ba). (C) MALDI analysis of the Bt247 toxin, with 34 μM (1,5mg/mL) of sample re-suspended in 100 μI water (70:30) and matrix SA dd (200 mg/mL; I/H20/TFA 70:30:0,1), confirms that the major crystal produced is a monomer of 44 kDa (expected for Cry6Ba). There are also different charges for the same toxin (bicharged = 44 kDa/ 2 charges = 22). Similarly, a small amount of dimer is detected (91 kDa). (D) elt-2(RNAi) worms are more susceptible to infection with the BT strains Bt243, Bt245, and Bt246. Difference in survival between N2 control and elt-2(RNAi) animals 24 h p.i. with additional nematicidal strains Bt243, Bt245 and Bt246. (E) Survival of N2 wildtype control animals 24 h p.i. with either wildtype Bt247, expressing the Cry6Ba toxin, or Bt247(-Cry6Ba), which lacks the toxin genes and was thus unable to kill C. elegans. (F) Boxplots show survival of N2 wildtype control animals 48 h p.i. with purified Cry6Ba toxin resuspended in PBS or in spore solutions of the indicated Bt strains. Purified Cry6Ba diluted with PBS or mixed together with Bt spores at a range of concentrations between 1:2 to 1:1000000 was not able to kill worms. (G) difference in survival between N2 wildtype controls and elt-2(RNAi) animals 24 h after exposure to different dilutions of a mix of crystal toxins purified from a culture of Bt679. (H) elt-2 is required for survival after exposure to the Bt679 PFT Cry21Aa3 but not Cry14Aa2. elt-2(RNAi) worms exposed to Bt679(-Cry) expressing either Cry14Aa2 (Cry14A), Cry21Aa3 (Cry21A) or RFP. Evolved Bt247 and Bt679 strains that have lost their Cry toxin genes are unable to kill nematode hosts, confirming that Bt247 and Bt679 Cry toxins are essential virulence factors (S3E and S3H Fig (RFP, green dots)). In E, G and H mean and SEM are shown, N = 4 (except for H, where N = 3) plates with 30 worms each. Statistics as in Fig 3. *** shows p-value < 0.001 comparing RNAi to wildtype N2 or empty vector controls. Bonferroni adjusted. Green dots in (E) represent survival of worms exposed to Bt407 and in (H) survival of worms exposed to Bt679(-Cry)+RFP. In D, G and H data represented in heatmap and statistics as in Fig 3E. We conclude that the level of specificity in the nematode’s response to Bt is not only determined by the pathogen strain, but at least to some extent by individual virulence factors.

    (TIF)

    S5 Fig. Sterility does not show pathogen strain-specific effects.

    Related to Fig 6. In (A, B) we show the difference in survival between the N2 control and (A) the sperm-deficient and sterile RNA-dependent RNA polymerase rrf-3(b26) mutant; (B) the LIN-12/Notch family of receptors member glp-1(ar202) and glp-1(bn18) sterile mutants. Triangles indicate significant difference compared to elt-2(RNAi). Sterile mutants had higher survival than controls both on Bt247 and Bt679, suggesting that the effect of sterility in our infections is not Bt strain specific. Knockdown of elt-2 in the rrf-3(b26), glp-1(ar202), and glp-1(bn18) mutant backgrounds further enhanced the increased survival rate observed in sterile mutants infected with Bt247 and produced higher survival rate on Bt679 than that of elt-2(RNAi) worms alone. Our results suggest that the increased survival rate of sterile mutants on Bt247 and Bt679 is independent of the effect of elt-2. The data represented in the heatmap and statistics as in Fig 3E. In (A-B) worms were grown on RNAi E. coli HT115 plates.

    (TIF)

    S6 Fig. Nuclear hormone receptor-encoding gene nhr-8 contributes to general responses to Bt. Related to Fig 7.

    Difference in survival between the N2 control and the nuclear hormone receptor mutants nhr-8(ok186). A GLM of the binomial family was fitted followed by a Tukey HSD Test (see methods section), where mutant or knockdown worm strains were compared to control strains. Asterisks show significant differences between knockout/knockdown treatment and wildtype N2 control. p-value Bonferroni adjusted. Data represented in heatmap and statistics as in Fig 3E. Triangles indicate significant difference compared to elt-2(RNAi).

    (TIF)

    S1 Table. Differential gene expression analysis of C. elegans N2 infected with B. thuringiensis Bt247 and Bt679.

    (XLSX)

    S2 Table. Results of functional enrichment analysis using DAVID per differential gene expression cluster of C. elegans N2 infected with B. thuringiensis Bt247 and Bt679.

    (XLSX)

    S3 Table. Results of functional enrichment analysis using WormExp per differential gene expression cluster of C. elegans N2 infected with B. thuringiensis Bt247 and Bt679.

    (XLSX)

    S4 Table. Differential gene expression analysis of C. elegans N2 elt-2(RNAi) worms infected with B. thuringiensis Bt247 and Bt679.

    (XLSX)

    S5 Table. Results of functional enrichment analysis using DAVID per differential gene expression cluster of C. elegans N2 elt-2(RNAi) worms infected with B. thuringiensis Bt247 and Bt679.

    (XLSX)

    S6 Table. List of worm and bacterial strains used in this study.

    (XLSX)

    S7 Table. List of oligonucleotides used in this study.

    (XLSX)

    S8 Table. Raw phenotypic data.

    (XLSX)

    S9 Table. Results of statistical tests performed on phenotypic datasets.

    (XLSX)

    Attachment

    Submitted filename: Zarate_Potes_et al_responses to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Pathogens are provided here courtesy of PLOS

    RESOURCES